RxNorm Semantic Concepts Index - 272
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "272".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 272 | Charcoal activated | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 272 | Charcoal activated | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 272 | Charcoal activated | Designated preferred name (PT) | YES | |
| RxCUI: 272 | Charcoal activated | Full form of descriptor (FN) | YES | |
| RxCUI: 272 | Charcoal activated | Designated preferred name (PT) | YES | |
| RxCUI: 272 | Charcoal activated | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 272 | Charcoal activated | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 272 | Charcoal activated | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 272 | Charcoal activated | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 272 | Charcoal activated | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 272 | Charcoal activated | Full form of descriptor (FN) | YES | |
| RxCUI: 2720022 | rocuronium Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2720024 | rocuronium bromide 50 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2720024 | rocuronium bromide 50 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720024 | rocuronium bromide 50 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720025 | rocuronium bromide 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2720026 | rocuronium bromide 100 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2720026 | rocuronium bromide 100 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720026 | rocuronium bromide 100 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720027 | petrolatum 0.797 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2720028 | menthol 0.35 % / petrolatum 79.65 % / zinc oxide 5 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2720028 | menthol 0.35 % / petrolatum 79.65 % / zinc oxide 5 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720028 | menthol 0.35 % / petrolatum 79.65 % / zinc oxide 5 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2720028 | menthol 0.35 % / petrolatum 79.65 % / zinc oxide 5 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720029 | Fluarix 2025-2026 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2720030 | influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML [Fluarix 2025-2026] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2720031 | Fluarix 2025-2026 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2720032 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix 2025-2026] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2720034 | FLUARIX 2025-2026 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2720034 | FLUARIX 2025-2026 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720034 | FLUARIX 2025-2026 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720035 | FLUARIX 2025-2026 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2720035 | FLUARIX 2025-2026 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720035 | FLUARIX 2025-2026 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2720068 | finerenone 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2720069 | finerenone 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720069 | finerenone 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2720070 | finerenone 40 MG [Kerendia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2720071 | Kerendia 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2720071 | Kerendia 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720071 | Kerendia 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720076 | piroctone olamine 0.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2720077 | piroctone olamine 0.08 % / salicylic acid 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2720077 | piroctone olamine 0.08 % / salicylic acid 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720077 | piroctone olamine 0.08 % / salicylic acid 2 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2720179 | Dioscorea cayenensis tuber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2720332 | Clemsza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2720333 | clemastine fumarate 2.68 MG [Clemsza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2720334 | Clemsza Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2720335 | Clemsza Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2720336 | clemastine Oral Tablet [Clemsza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2720338 | CLEMSZA 2.68 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2720338 | CLEMSZA 2.68 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720338 | CLEMSZA 2.68 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720340 | Vabrinty | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2720341 | leuprolide acetate 60 MG/ML [Vabrinty] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2720342 | Vabrinty Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2720343 | leuprolide Prefilled Syringe [Vabrinty] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2720345 | Vabrinty 22.5 MG in 0.375 ML (3 month) Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2720345 | Vabrinty 22.5 MG in 0.375 ML (3 month) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720345 | Vabrinty 22.5 MG in 0.375 ML (3 month) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720346 | Vabrinty 60 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2720346 | Vabrinty 60 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2720346 | Vabrinty 60 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720347 | leuprolide acetate 120 MG/ML [Vabrinty] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2720348 | Vabrinty 45 MG in 0.375 ML (6 month) Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2720348 | Vabrinty 45 MG in 0.375 ML (6 month) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720348 | Vabrinty 45 MG in 0.375 ML (6 month) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720349 | Vabrinty 120 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2720349 | Vabrinty 120 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2720349 | Vabrinty 120 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720350 | Lurbiro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2720351 | flurbiprofen 100 MG [Lurbiro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2720352 | Lurbiro Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2720353 | Lurbiro Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2720354 | flurbiprofen Oral Tablet [Lurbiro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2720355 | LURBIRO 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2720355 | LURBIRO 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720355 | LURBIRO 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720356 | iloperidone 1 MG Oral Tablet (6) / iloperidone 2 MG Oral Tablet (2) / iloperidone 6 MG Oral Tablet (2) / iloperidone 8 MG Oral Tablet (2) Titration Pack B | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2720356 | iloperidone 1 MG Oral Tablet (6) / iloperidone 2 MG Oral Tablet (2) / iloperidone 6 MG Oral Tablet (2) / iloperidone 8 MG Oral Tablet (2) Titration Pack B | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720357 | Fanapt Titration Pack B | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2720357 | Fanapt Titration Pack B | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720357 | Fanapt Titration Pack B | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720359 | influenza A virus A/Perth/722/2024 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2720366 | FluMist 2025-2026 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2720368 | FluMist 2025-2026 Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2720369 | FluMist 2025-2026 Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2720370 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [FluMist 2025-2026] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2720397 | influenza A virus A/Perth/722/2024 (H3N2) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2720398 | influenza virus vaccine 2025-2026 Nasal Spray (Home Administration) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2720398 | influenza virus vaccine 2025-2026 Nasal Spray (Home Administration) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720398 | influenza virus vaccine 2025-2026 Nasal Spray (Home Administration) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720399 | influenza A virus A/Norway/31694/2022 (H1N1) antigen 158000000 UNT/ML / influenza A virus A/Perth/722/2024 (H3N2) antigen 158000000 UNT/ML / influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML [FluMist 2025-2026] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 27204 | Hydrogenase (NAD^+^) | Designated preferred name (PT) | NO | |
| RxCUI: 27204 | Hydrogenase (NAD^+^) | Full form of descriptor (FN) | NO | |
| RxCUI: 27204 | Hydrogenase (NAD^+^) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720400 | FluMist 2025-2026 Formula Nasal Spray (Home Administration) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720400 | FluMist 2025-2026 Formula Nasal Spray (Home Administration) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720400 | FluMist 2025-2026 Formula Nasal Spray (Home Administration) | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2720401 | influenza virus vaccine 2025-2026 Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2720401 | influenza virus vaccine 2025-2026 Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720401 | influenza virus vaccine 2025-2026 Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720402 | FluMist 2025-2026 Formula Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720402 | FluMist 2025-2026 Formula Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720402 | FluMist 2025-2026 Formula Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2720403 | camphor 10 % / menthol 15 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2720403 | camphor 10 % / menthol 15 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720403 | camphor 10 % / menthol 15 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2720404 | menthol 1.5 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2720404 | menthol 1.5 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720404 | menthol 1.5 % Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2720510 | ustekinumab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2720512 | ustekinumab-ttwe 45 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2720512 | ustekinumab-ttwe 45 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720512 | ustekinumab-ttwe 45 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720512 | ustekinumab-ttwe 45 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720513 | ustekinumab-ttwe 90 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2720514 | ustekinumab Auto-Injector [Pyzchiva] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2720516 | Pyzchiva 45 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2720516 | Pyzchiva 45 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720516 | Pyzchiva 45 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720516 | Pyzchiva 45 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720517 | ustekinumab-ttwe 90 MG/ML Auto-Injector [Pyzchiva] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720517 | ustekinumab-ttwe 90 MG/ML Auto-Injector [Pyzchiva] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2720519 | insulin aspart-xjhz | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2720520 | insulin aspart-xjhz 100 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2720523 | insulin aspart-xjhz 100 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720523 | insulin aspart-xjhz 100 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2720524 | Kirsty | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2720525 | insulin aspart-xjhz 100 UNT/ML [Kirsty] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2720526 | Kirsty Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2720527 | insulin aspart, human Injectable Solution [Kirsty] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2720529 | Kirsty 100 UNT/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2720529 | Kirsty 100 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720529 | Kirsty 100 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720535 | insulin aspart, human Pen Injector [Kirsty] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2720539 | insulin aspart-xjhz 100 UNT/ML in 3 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2720539 | insulin aspart-xjhz 100 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720539 | insulin aspart-xjhz 100 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720540 | insulin aspart-xjhz 100 UNT/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2720541 | Kirsty 100 UNT/ML in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2720541 | Kirsty 100 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720541 | Kirsty 100 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720542 | insulin aspart-xjhz 100 UNT/ML Pen Injector [Kirsty] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2720542 | insulin aspart-xjhz 100 UNT/ML Pen Injector [Kirsty] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720545 | Inactivated whole Vibrio cholerae and Vibrio cholerae recombinant toxin B subunit antigens only vaccine product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2720545 | Inactivated whole Vibrio cholerae and Vibrio cholerae recombinant toxin B subunit antigens only vaccine product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2720546 | Influenza H5N8 vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2720546 | Influenza H5N8 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720546 | Influenza H5N8 vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2720547 | Pneumococcal 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, deOAc15B (de-O-acetylated 15B), 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, 35B conjugate vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720547 | Pneumococcal 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, deOAc15B (de-O-acetylated 15B), 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, 35B conjugate vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720547 | Pneumococcal 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, deOAc15B (de-O-acetylated 15B), 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, 35B conjugate vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2720547 | Pneumococcal 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, deOAc15B (de-O-acetylated 15B), 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, 35B conjugate vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2720548 | Amikacin only product in pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2720548 | Amikacin only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2720549 | Aspirin and clopidogrel only product | Designated preferred name (PT) | NO | |
| RxCUI: 2720549 | Aspirin and clopidogrel only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2720550 | Aspirin and clopidogrel only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2720550 | Aspirin and clopidogrel only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2720551 | Bacterial lysate only product | Designated preferred name (PT) | NO | |
| RxCUI: 2720551 | Bacterial lysate only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2720552 | Bacterial lysate only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2720552 | Bacterial lysate only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2720553 | Fluorine-18 only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2720553 | Fluorine-18 only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2720555 | Amidine antiseptic | Designated preferred name (PT) | NO | |
| RxCUI: 2720555 | Amidine antiseptic | Full form of descriptor (FN) | NO | |
| RxCUI: 2720557 | Antibody to influenza virus | Designated preferred name (PT) | NO | |
| RxCUI: 2720557 | Antibody to influenza virus | Full form of descriptor (FN) | NO | |
| RxCUI: 2720558 | Antigen of Bacillus pumilus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720558 | Antigen of Bacillus pumilus | Full form of descriptor (FN) | NO | |
| RxCUI: 2720558 | Antigen of Bacillus pumilus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720558 | Antigen of Bacillus pumilus | Designated preferred name (PT) | NO | |
| RxCUI: 2720559 | Antigen of Clostridium butyricum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720559 | Antigen of Clostridium butyricum | Full form of descriptor (FN) | NO | |
| RxCUI: 2720559 | Antigen of Clostridium butyricum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720559 | Antigen of Clostridium butyricum | Designated preferred name (PT) | NO | |
| RxCUI: 2720560 | Antigen of epidermal growth factor receptor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720560 | Antigen of epidermal growth factor receptor | Full form of descriptor (FN) | NO | |
| RxCUI: 2720560 | Antigen of epidermal growth factor receptor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720560 | Antigen of epidermal growth factor receptor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720560 | Antigen of epidermal growth factor receptor | Designated preferred name (PT) | NO | |
| RxCUI: 2720568 | Antigen of Heyndrickxia coagulans | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720568 | Antigen of Heyndrickxia coagulans | Full form of descriptor (FN) | NO | |
| RxCUI: 2720568 | Antigen of Heyndrickxia coagulans | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720568 | Antigen of Heyndrickxia coagulans | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720568 | Antigen of Heyndrickxia coagulans | Designated preferred name (PT) | NO | |
| RxCUI: 2720572 | Antigen of Influenza A virus A/Wisconsin/67/2022 (H1N1)pdm09-like virus strain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720572 | Antigen of Influenza A virus A/Wisconsin/67/2022 (H1N1)pdm09-like virus strain | Full form of descriptor (FN) | NO | |
| RxCUI: 2720572 | Antigen of Influenza A virus A/Wisconsin/67/2022 (H1N1)pdm09-like virus strain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720572 | Antigen of Influenza A virus A/Wisconsin/67/2022 (H1N1)pdm09-like virus strain | Designated preferred name (PT) | NO | |
| RxCUI: 2720573 | Antigen of Influenza A virus subtype H5 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720573 | Antigen of Influenza A virus subtype H5 | Full form of descriptor (FN) | NO | |
| RxCUI: 2720573 | Antigen of Influenza A virus subtype H5 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720573 | Antigen of Influenza A virus subtype H5 | Designated preferred name (PT) | NO | |
| RxCUI: 2720574 | Antigen of Influenza A virus subtype H5N8 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720574 | Antigen of Influenza A virus subtype H5N8 | Full form of descriptor (FN) | NO | |
| RxCUI: 2720574 | Antigen of Influenza A virus subtype H5N8 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720574 | Antigen of Influenza A virus subtype H5N8 | Designated preferred name (PT) | NO | |
| RxCUI: 2720575 | Antigen of Streptococcus pneumoniae Danish serotype 15A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720575 | Antigen of Streptococcus pneumoniae Danish serotype 15A capsular polysaccharide | Full form of descriptor (FN) | NO | |
| RxCUI: 2720575 | Antigen of Streptococcus pneumoniae Danish serotype 15A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720575 | Antigen of Streptococcus pneumoniae Danish serotype 15A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720575 | Antigen of Streptococcus pneumoniae Danish serotype 15A capsular polysaccharide | Designated preferred name (PT) | NO | |
| RxCUI: 2720576 | Antigen of Streptococcus pneumoniae Danish serotype 16F capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720576 | Antigen of Streptococcus pneumoniae Danish serotype 16F capsular polysaccharide | Full form of descriptor (FN) | NO | |
| RxCUI: 2720576 | Antigen of Streptococcus pneumoniae Danish serotype 16F capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720576 | Antigen of Streptococcus pneumoniae Danish serotype 16F capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720576 | Antigen of Streptococcus pneumoniae Danish serotype 16F capsular polysaccharide | Designated preferred name (PT) | NO | |
| RxCUI: 2720577 | Antigen of Streptococcus pneumoniae Danish serotype 20A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720577 | Antigen of Streptococcus pneumoniae Danish serotype 20A capsular polysaccharide | Full form of descriptor (FN) | NO | |
| RxCUI: 2720577 | Antigen of Streptococcus pneumoniae Danish serotype 20A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720577 | Antigen of Streptococcus pneumoniae Danish serotype 20A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720577 | Antigen of Streptococcus pneumoniae Danish serotype 20A capsular polysaccharide | Designated preferred name (PT) | NO | |
| RxCUI: 2720578 | Antigen of Streptococcus pneumoniae Danish serotype 23A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720578 | Antigen of Streptococcus pneumoniae Danish serotype 23A capsular polysaccharide | Full form of descriptor (FN) | NO | |
| RxCUI: 2720578 | Antigen of Streptococcus pneumoniae Danish serotype 23A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720578 | Antigen of Streptococcus pneumoniae Danish serotype 23A capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720578 | Antigen of Streptococcus pneumoniae Danish serotype 23A capsular polysaccharide | Designated preferred name (PT) | NO | |
| RxCUI: 2720579 | Antigen of Streptococcus pneumoniae Danish serotype 23B capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720579 | Antigen of Streptococcus pneumoniae Danish serotype 23B capsular polysaccharide | Full form of descriptor (FN) | NO | |
| RxCUI: 2720579 | Antigen of Streptococcus pneumoniae Danish serotype 23B capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720579 | Antigen of Streptococcus pneumoniae Danish serotype 23B capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720579 | Antigen of Streptococcus pneumoniae Danish serotype 23B capsular polysaccharide | Designated preferred name (PT) | NO | |
| RxCUI: 2720580 | Antigen of Streptococcus pneumoniae Danish serotype 24F capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720580 | Antigen of Streptococcus pneumoniae Danish serotype 24F capsular polysaccharide | Full form of descriptor (FN) | NO | |
| RxCUI: 2720580 | Antigen of Streptococcus pneumoniae Danish serotype 24F capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720580 | Antigen of Streptococcus pneumoniae Danish serotype 24F capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720580 | Antigen of Streptococcus pneumoniae Danish serotype 24F capsular polysaccharide | Designated preferred name (PT) | NO | |
| RxCUI: 2720581 | Antigen of Streptococcus pneumoniae Danish serotype 31 capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720581 | Antigen of Streptococcus pneumoniae Danish serotype 31 capsular polysaccharide | Full form of descriptor (FN) | NO | |
| RxCUI: 2720581 | Antigen of Streptococcus pneumoniae Danish serotype 31 capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720581 | Antigen of Streptococcus pneumoniae Danish serotype 31 capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720581 | Antigen of Streptococcus pneumoniae Danish serotype 31 capsular polysaccharide | Designated preferred name (PT) | NO | |
| RxCUI: 2720582 | Antigen of Streptococcus pneumoniae Danish serotype 35B capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720582 | Antigen of Streptococcus pneumoniae Danish serotype 35B capsular polysaccharide | Full form of descriptor (FN) | NO | |
| RxCUI: 2720582 | Antigen of Streptococcus pneumoniae Danish serotype 35B capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720582 | Antigen of Streptococcus pneumoniae Danish serotype 35B capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720582 | Antigen of Streptococcus pneumoniae Danish serotype 35B capsular polysaccharide | Designated preferred name (PT) | NO | |
| RxCUI: 2720584 | Aspirin 75 mg and clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2720584 | Aspirin 75 mg and clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2720585 | Azithromycin monohydrate hemi-ethanolate | Designated preferred name (PT) | NO | |
| RxCUI: 2720585 | Azithromycin monohydrate hemi-ethanolate | Full form of descriptor (FN) | NO | |
| RxCUI: 2720586 | Bacterial isolate | Designated preferred name (PT) | NO | |
| RxCUI: 2720586 | Bacterial isolate | Full form of descriptor (FN) | NO | |
| RxCUI: 2720587 | Aspirin- and clopidogrel-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2720587 | Aspirin- and clopidogrel-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2720588 | Aspirin- and clopidogrel-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2720588 | Aspirin- and clopidogrel-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2720589 | Bacterial lysate | Designated preferred name (PT) | NO | |
| RxCUI: 2720589 | Bacterial lysate | Full form of descriptor (FN) | NO | |
| RxCUI: 2720590 | Bacterial lysate 3.5 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2720590 | Bacterial lysate 3.5 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2720591 | Bacterial lysate 7 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2720591 | Bacterial lysate 7 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2720592 | Bacterial lysate-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2720592 | Bacterial lysate-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2720593 | Bacterial lysate-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2720593 | Bacterial lysate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2720594 | Barbiturate general intravenous anaesthetic | British preferred term (PTGB) | NO | |
| RxCUI: 2720594 | Barbiturate general intravenous anaesthetic | Designated preferred name (PT) | NO | |
| RxCUI: 2720594 | Barbiturate general intravenous anaesthetic | Full form of descriptor (FN) | NO | |
| RxCUI: 2720595 | Benzoic acid ester local anaesthetic | British preferred term (PTGB) | NO | |
| RxCUI: 2720595 | Benzoic acid ester local anaesthetic | Designated preferred name (PT) | NO | |
| RxCUI: 2720595 | Benzoic acid ester local anaesthetic | Full form of descriptor (FN) | NO | |
| RxCUI: 2720596 | Benzyl benzoate- and disulfiram-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2720596 | Benzyl benzoate- and disulfiram-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2720597 | Biguanide hypoglycaemic agent | British preferred term (PTGB) | NO | |
| RxCUI: 2720597 | Biguanide hypoglycaemic agent | Designated preferred name (PT) | NO | |
| RxCUI: 2720597 | Biguanide hypoglycaemic agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2720696 | Cefprozil monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2720696 | Cefprozil monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2720697 | Codeine monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2720697 | Codeine monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2720698 | Codeine sulfate trihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2720698 | Codeine sulfate trihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2720698 | Codeine sulfate trihydrate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720699 | Copper (64-Cu) labeled PSMA (prostate specific membrane antigen) | Designated preferred name (PT) | NO | |
| RxCUI: 2720699 | Copper (64-Cu) labeled PSMA (prostate specific membrane antigen) | Full form of descriptor (FN) | NO | |
| RxCUI: 2720699 | Copper (64-Cu) labeled PSMA (prostate specific membrane antigen) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720699 | Copper (64-Cu) labeled PSMA (prostate specific membrane antigen) | British preferred term (PTGB) | NO | |
| RxCUI: 2720699 | Copper (64-Cu) labeled PSMA (prostate specific membrane antigen) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720699 | Copper (64-Cu) labeled PSMA (prostate specific membrane antigen) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720701 | Copper (64-Cu) somatostatin analog | Designated preferred name (PT) | NO | |
| RxCUI: 2720701 | Copper (64-Cu) somatostatin analog | Full form of descriptor (FN) | NO | |
| RxCUI: 2720701 | Copper (64-Cu) somatostatin analog | British preferred term (PTGB) | NO | |
| RxCUI: 2720701 | Copper (64-Cu) somatostatin analog | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720701 | Copper (64-Cu) somatostatin analog | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720706 | Dasatinib (S)-propylene glycol | Designated preferred name (PT) | NO | |
| RxCUI: 2720706 | Dasatinib (S)-propylene glycol | Full form of descriptor (FN) | NO | |
| RxCUI: 2720710 | Dibromodicyanobutane-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720711 | Digitalis extract | Designated preferred name (PT) | NO | |
| RxCUI: 2720711 | Digitalis extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2720713 | DNA mismatch repair protein | Designated preferred name (PT) | NO | |
| RxCUI: 2720713 | DNA mismatch repair protein | Full form of descriptor (FN) | NO | |
| RxCUI: 2720714 | Echis carinatus viper venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720714 | Echis carinatus viper venom | Full form of descriptor (FN) | NO | |
| RxCUI: 2720714 | Echis carinatus viper venom | Designated preferred name (PT) | NO | |
| RxCUI: 2720715 | Edoxaban tosilate monohydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720715 | Edoxaban tosilate monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2720715 | Edoxaban tosilate monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2720718 | Exendin | Designated preferred name (PT) | NO | |
| RxCUI: 2720718 | Exendin | Full form of descriptor (FN) | NO | |
| RxCUI: 2720720 | Fifth generation cephalosporin | Designated preferred name (PT) | NO | |
| RxCUI: 2720720 | Fifth generation cephalosporin | Full form of descriptor (FN) | NO | |
| RxCUI: 2720721 | Finished dosage form | Designated preferred name (PT) | NO | |
| RxCUI: 2720721 | Finished dosage form | Full form of descriptor (FN) | NO | |
| RxCUI: 2720722 | Finished medicinal product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720723 | Finished product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720724 | Fluorine (18-F) labeled PSMA (prostate specific membrane antigen) | Designated preferred name (PT) | NO | |
| RxCUI: 2720724 | Fluorine (18-F) labeled PSMA (prostate specific membrane antigen) | Full form of descriptor (FN) | NO | |
| RxCUI: 2720724 | Fluorine (18-F) labeled PSMA (prostate specific membrane antigen) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720724 | Fluorine (18-F) labeled PSMA (prostate specific membrane antigen) | British preferred term (PTGB) | NO | |
| RxCUI: 2720724 | Fluorine (18-F) labeled PSMA (prostate specific membrane antigen) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720724 | Fluorine (18-F) labeled PSMA (prostate specific membrane antigen) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720727 | Gallium (68-Ga) exendin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720727 | Gallium (68-Ga) exendin | Designated preferred name (PT) | NO | |
| RxCUI: 2720727 | Gallium (68-Ga) exendin | Full form of descriptor (FN) | NO | |
| RxCUI: 2720727 | Gallium (68-Ga) exendin | British preferred term (PTGB) | NO | |
| RxCUI: 2720729 | Gallium (68-Ga) labeled PSMA (prostate specific membrane antigen) | Designated preferred name (PT) | NO | |
| RxCUI: 2720729 | Gallium (68-Ga) labeled PSMA (prostate specific membrane antigen) | Full form of descriptor (FN) | NO | |
| RxCUI: 2720729 | Gallium (68-Ga) labeled PSMA (prostate specific membrane antigen) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720729 | Gallium (68-Ga) labeled PSMA (prostate specific membrane antigen) | British preferred term (PTGB) | NO | |
| RxCUI: 2720729 | Gallium (68-Ga) labeled PSMA (prostate specific membrane antigen) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720729 | Gallium (68-Ga) labeled PSMA (prostate specific membrane antigen) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720731 | Fluorine-18-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2720731 | Fluorine-18-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2720732 | Fluorouracil- and salicylic acid-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2720732 | Fluorouracil- and salicylic acid-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2720733 | Fluorouracil- and salicylic acid-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2720733 | Fluorouracil- and salicylic acid-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2720734 | Gallium (68-Ga) somatostatin analog | Designated preferred name (PT) | NO | |
| RxCUI: 2720734 | Gallium (68-Ga) somatostatin analog | Full form of descriptor (FN) | NO | |
| RxCUI: 2720734 | Gallium (68-Ga) somatostatin analog | British preferred term (PTGB) | NO | |
| RxCUI: 2720734 | Gallium (68-Ga) somatostatin analog | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720734 | Gallium (68-Ga) somatostatin analog | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720752 | Lutetium (177-Lu) labeled PSMA (prostate specific membrane antigen) | Designated preferred name (PT) | NO | |
| RxCUI: 2720752 | Lutetium (177-Lu) labeled PSMA (prostate specific membrane antigen) | Full form of descriptor (FN) | NO | |
| RxCUI: 2720752 | Lutetium (177-Lu) labeled PSMA (prostate specific membrane antigen) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720752 | Lutetium (177-Lu) labeled PSMA (prostate specific membrane antigen) | British preferred term (PTGB) | NO | |
| RxCUI: 2720752 | Lutetium (177-Lu) labeled PSMA (prostate specific membrane antigen) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720752 | Lutetium (177-Lu) labeled PSMA (prostate specific membrane antigen) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720758 | Mineral oil- and paraffin wax- and wool alcohol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720759 | PHOX2B homeodomain protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720759 | PHOX2B homeodomain protein | Designated preferred name (PT) | NO | |
| RxCUI: 2720759 | PHOX2B homeodomain protein | Full form of descriptor (FN) | NO | |
| RxCUI: 2720759 | PHOX2B homeodomain protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720759 | PHOX2B homeodomain protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720765 | Olanzapine tartrate | Designated preferred name (PT) | NO | |
| RxCUI: 2720765 | Olanzapine tartrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2720766 | PSTI - pancreatic secretory trypsin inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2720766 | PSTI - pancreatic secretory trypsin inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2720766 | PSTI - pancreatic secretory trypsin inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720768 | Pantoprazole magnesium hemipentahydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2720768 | Pantoprazole magnesium hemipentahydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2720769 | Paroxetine hydrochloride acetone solvate | Designated preferred name (PT) | NO | |
| RxCUI: 2720769 | Paroxetine hydrochloride acetone solvate | Full form of descriptor (FN) | NO | |
| RxCUI: 2720775 | Prostate specific membrane antigen | Designated preferred name (PT) | NO | |
| RxCUI: 2720775 | Prostate specific membrane antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 2720776 | Radioisotope labeled PSMA (prostate specific membrane antigen) | Designated preferred name (PT) | NO | |
| RxCUI: 2720776 | Radioisotope labeled PSMA (prostate specific membrane antigen) | Full form of descriptor (FN) | NO | |
| RxCUI: 2720776 | Radioisotope labeled PSMA (prostate specific membrane antigen) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720776 | Radioisotope labeled PSMA (prostate specific membrane antigen) | British preferred term (PTGB) | NO | |
| RxCUI: 2720776 | Radioisotope labeled PSMA (prostate specific membrane antigen) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720778 | Risperidone tartrate | Designated preferred name (PT) | NO | |
| RxCUI: 2720778 | Risperidone tartrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2720779 | SPINK1 - serine protease inhibitor Kazal type 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720781 | Siderophore cephalosporin | Designated preferred name (PT) | NO | |
| RxCUI: 2720781 | Siderophore cephalosporin | Full form of descriptor (FN) | NO | |
| RxCUI: 2720799 | Technetium (99m-Tc) labeled PSMA (prostate specific membrane antigen) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720799 | Technetium (99m-Tc) labeled PSMA (prostate specific membrane antigen) | Designated preferred name (PT) | NO | |
| RxCUI: 2720799 | Technetium (99m-Tc) labeled PSMA (prostate specific membrane antigen) | Full form of descriptor (FN) | NO | |
| RxCUI: 2720799 | Technetium (99m-Tc) labeled PSMA (prostate specific membrane antigen) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2720799 | Technetium (99m-Tc) labeled PSMA (prostate specific membrane antigen) | British preferred term (PTGB) | NO | |
| RxCUI: 2720799 | Technetium (99m-Tc) labeled PSMA (prostate specific membrane antigen) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 27208 | hydroiodic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2720803 | Ursodeoxycholylglycine | Designated preferred name (PT) | NO | |
| RxCUI: 2720803 | Ursodeoxycholylglycine | Full form of descriptor (FN) | NO | |
| RxCUI: 2720804 | nalmefene 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2720805 | nalmefene Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2720806 | nalmefene 1.5 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2720806 | nalmefene 1.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720806 | nalmefene 1.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720806 | nalmefene 1.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720807 | nalmefene 3 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2720807 | nalmefene 3 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2720808 | Zurnai | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2720809 | nalmefene 3 MG/ML [Zurnai] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2720810 | Zurnai Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2720811 | nalmefene Auto-Injector [Zurnai] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2720812 | Zurnai 1.5 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2720812 | Zurnai 1.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2720812 | Zurnai 1.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2720813 | Zurnai 3 MG/ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2720813 | Zurnai 3 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2720813 | Zurnai 3 MG/ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2721095 | Technetium (99m-Tc) besilesomab | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2721095 | Technetium (99m-Tc) besilesomab | Designated preferred name (PT) | NO | |
| RxCUI: 2721095 | Technetium (99m-Tc) besilesomab | Full form of descriptor (FN) | NO | |
| RxCUI: 2721095 | Technetium (99m-Tc) besilesomab | British preferred term (PTGB) | NO | |
| RxCUI: 2721097 | Technetium (99m-Tc) monoclonal antibody | Designated preferred name (PT) | NO | |
| RxCUI: 2721097 | Technetium (99m-Tc) monoclonal antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 2721097 | Technetium (99m-Tc) monoclonal antibody | British preferred term (PTGB) | NO | |
| RxCUI: 2721097 | Technetium (99m-Tc) monoclonal antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2721100 | Technetium (99m-Tc) somatostatin analog | Designated preferred name (PT) | NO | |
| RxCUI: 2721100 | Technetium (99m-Tc) somatostatin analog | Full form of descriptor (FN) | NO | |
| RxCUI: 2721100 | Technetium (99m-Tc) somatostatin analog | British preferred term (PTGB) | NO | |
| RxCUI: 2721100 | Technetium (99m-Tc) somatostatin analog | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2721100 | Technetium (99m-Tc) somatostatin analog | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2721102 | Telmisartan sodium | Designated preferred name (PT) | NO | |
| RxCUI: 2721102 | Telmisartan sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 2721103 | Tenofovir alafenamide hemifumarate | Designated preferred name (PT) | NO | |
| RxCUI: 2721103 | Tenofovir alafenamide hemifumarate | Full form of descriptor (FN) | NO | |
| RxCUI: 2721104 | Vernakalant hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 2721104 | Vernakalant hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 2721105 | Volatile liquid anaesthetic | British preferred term (PTGB) | NO | |
| RxCUI: 2721105 | Volatile liquid anaesthetic | Designated preferred name (PT) | NO | |
| RxCUI: 2721105 | Volatile liquid anaesthetic | Full form of descriptor (FN) | NO | |
| RxCUI: 2721106 | Wool alcohol 2 mg/g eye ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2721108 | Wool alcohol-containing product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2721109 | allantoin 2 % / dimethicone 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721109 | allantoin 2 % / dimethicone 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721109 | allantoin 2 % / dimethicone 5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721163 | delgocitinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2721164 | delgocitinib 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721165 | delgocitinib Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2721166 | delgocitinib Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2721167 | delgocitinib 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721167 | delgocitinib 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721167 | delgocitinib 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721168 | Anzupgo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2721169 | delgocitinib 20 MG/ML [Anzupgo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721170 | Anzupgo Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721171 | delgocitinib Topical Cream [Anzupgo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2721172 | Anzupgo 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721172 | Anzupgo 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721172 | Anzupgo 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721185 | avatrombopag 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721186 | avatrombopag Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2721187 | avatrombopag Oral Granules | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2721188 | avatrombopag 10 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721188 | avatrombopag 10 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721188 | avatrombopag 10 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721189 | avatrombopag 10 MG [Doptelet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721190 | Doptelet Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721191 | avatrombopag Oral Granules [Doptelet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2721192 | Doptelet Sprinkle 10 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721192 | Doptelet Sprinkle 10 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721192 | Doptelet Sprinkle 10 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721193 | dordaviprone hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2721194 | dordaviprone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2721195 | dordaviprone 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721196 | dordaviprone Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2721197 | dordaviprone Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2721198 | dordaviprone Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2721199 | dordaviprone 125 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721199 | dordaviprone 125 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721199 | dordaviprone 125 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721200 | Modeyso | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2721201 | dordaviprone 125 MG [Modeyso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721202 | Modeyso Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721203 | Modeyso Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721204 | dordaviprone Oral Capsule [Modeyso] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2721205 | MODEYSO 125 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721205 | MODEYSO 125 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721205 | MODEYSO 125 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721413 | zeaxanthin 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721414 | lutein 10 MG / zeaxanthin 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721414 | lutein 10 MG / zeaxanthin 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721415 | lutein / zeaxanthin Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2721416 | lutein / zeaxanthin Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2721417 | lutein 10 MG / zeaxanthin 2 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721417 | lutein 10 MG / zeaxanthin 2 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721420 | PeriGuard Ointment | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2721422 | PeriGuard Ointment Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721423 | petrolatum Topical Ointment [PeriGuard Ointment] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2721425 | petrolatum 0.499 MG/MG [PeriGuard Ointment] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721426 | PeriGuard 49.9 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721426 | PeriGuard 49.9 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721426 | PeriGuard 49.9 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721430 | ustekinumab-ttwe 90 MG in 1 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721430 | ustekinumab-ttwe 90 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721430 | ustekinumab-ttwe 90 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721430 | ustekinumab-ttwe 90 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721431 | Pyzchiva 90 MG in 1 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721431 | Pyzchiva 90 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721431 | Pyzchiva 90 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721431 | Pyzchiva 90 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721462 | hypochlorous acid 0.01 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2721462 | hypochlorous acid 0.01 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2721462 | hypochlorous acid 0.01 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2721463 | futibatinib 16 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721464 | futibatinib 16 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721464 | futibatinib 16 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721465 | futibatinib 16 MG [Lytgobi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721466 | LYTGOBI 16 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721466 | LYTGOBI 16 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721466 | LYTGOBI 16 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721467 | futibatinib 20 MG Daily Dose Pack, 4 MG (7), 16 MG (7) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2721467 | futibatinib 20 MG Daily Dose Pack, 4 MG (7), 16 MG (7) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721467 | futibatinib 20 MG Daily Dose Pack, 4 MG (7), 16 MG (7) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721468 | LYTGOBI 20 MG Daily Dose - 4 MG (7), 16 MG (7) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2721468 | LYTGOBI 20 MG Daily Dose - 4 MG (7), 16 MG (7) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721468 | LYTGOBI 20 MG Daily Dose - 4 MG (7), 16 MG (7) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721469 | futibatinib 16 MG Daily Dose Pack, 16 MG (7) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2721469 | futibatinib 16 MG Daily Dose Pack, 16 MG (7) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721469 | futibatinib 16 MG Daily Dose Pack, 16 MG (7) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721470 | LYTGOBI 16 MG Daily Dose - 16 MG (7) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2721470 | LYTGOBI 16 MG Daily Dose - 16 MG (7) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721470 | LYTGOBI 16 MG Daily Dose - 16 MG (7) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721527 | celecoxib 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721528 | celecoxib Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2721529 | celecoxib 10 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721529 | celecoxib 10 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721529 | celecoxib 10 MG in 1 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721530 | Vyscoxa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2721531 | celecoxib 10 MG/ML [Vyscoxa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721532 | Vyscoxa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721533 | Vyscoxa Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721534 | celecoxib Oral Suspension [Vyscoxa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2721535 | VYSCOXA 10 MG in 1 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721535 | VYSCOXA 10 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721535 | VYSCOXA 10 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721535 | VYSCOXA 10 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721598 | Kyxata | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2721599 | carboplatin 10 MG/ML [Kyxata] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721599 | carboplatin 10 MG/ML [Kyxata] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2721600 | Kyxata Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721601 | carboplatin Injectable Solution [Kyxata] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2721601 | carboplatin Injectable Solution [Kyxata] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2721602 | KYXATA 10 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721602 | KYXATA 10 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2721602 | KYXATA 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721602 | KYXATA 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721602 | KYXATA 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721602 | KYXATA 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721603 | salicylic acid 5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2721603 | salicylic acid 5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2721603 | salicylic acid 5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2721604 | zongertinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2721605 | zongertinib 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721606 | zongertinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2721607 | zongertinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2721608 | zongertinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2721609 | zongertinib 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721609 | zongertinib 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721610 | Hernexeos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2721611 | zongertinib 60 MG [Hernexeos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721612 | Hernexeos Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721613 | Hernexeos Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721614 | zongertinib Oral Tablet [Hernexeos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2721615 | HERNEXEOS 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721615 | HERNEXEOS 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721615 | HERNEXEOS 60 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721765 | eta-tocopherol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2721766 | aceclidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2721767 | aceclidine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2721768 | aceclidine 14.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721769 | aceclidine Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2721770 | aceclidine Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2721771 | aceclidine 1.44 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721771 | aceclidine 1.44 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721771 | aceclidine 1.44 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721771 | aceclidine 1.44 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721772 | Vizz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2721773 | aceclidine 14.4 MG/ML [Vizz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721774 | Vizz Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721775 | aceclidine Ophthalmic Solution [Vizz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2721776 | VIZZ 1.44 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721776 | VIZZ 1.44 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721776 | VIZZ 1.44 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721776 | VIZZ 1.44 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721784 | lonapegsomatropin-tcgd 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721785 | lonapegsomatropin-tcgd 2.5 MG Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721785 | lonapegsomatropin-tcgd 2.5 MG Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721786 | lonapegsomatropin-tcgd 2.5 MG [Skytrofa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721787 | Skytrofa 2.5 MG Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721787 | Skytrofa 2.5 MG Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721787 | Skytrofa 2.5 MG Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721788 | lonapegsomatropin-tcgd 2.1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721789 | lonapegsomatropin-tcgd 2.1 MG Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721789 | lonapegsomatropin-tcgd 2.1 MG Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721790 | lonapegsomatropin-tcgd 2.1 MG [Skytrofa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721791 | Skytrofa 2.1 MG Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721791 | Skytrofa 2.1 MG Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721791 | Skytrofa 2.1 MG Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721792 | lonapegsomatropin-tcgd 1.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721793 | lonapegsomatropin-tcgd 1.8 MG Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721793 | lonapegsomatropin-tcgd 1.8 MG Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721794 | lonapegsomatropin-tcgd 1.8 MG [Skytrofa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721795 | Skytrofa 1.8 MG Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721795 | Skytrofa 1.8 MG Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721795 | Skytrofa 1.8 MG Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721796 | lonapegsomatropin-tcgd 1.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721797 | lonapegsomatropin-tcgd 1.4 MG Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721797 | lonapegsomatropin-tcgd 1.4 MG Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721798 | lonapegsomatropin-tcgd 1.4 MG [Skytrofa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721799 | Skytrofa 1.4 MG Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721799 | Skytrofa 1.4 MG Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721799 | Skytrofa 1.4 MG Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721800 | lonapegsomatropin-tcgd 0.7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721801 | lonapegsomatropin-tcgd 0.7 MG Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721801 | lonapegsomatropin-tcgd 0.7 MG Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721802 | lonapegsomatropin-tcgd 0.7 MG [Skytrofa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721803 | Skytrofa 0.7 MG Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721803 | Skytrofa 0.7 MG Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721803 | Skytrofa 0.7 MG Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721880 | brensocatib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2721881 | brensocatib 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721882 | brensocatib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2721883 | brensocatib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2721884 | brensocatib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2721885 | brensocatib 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721885 | brensocatib 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721886 | Brinsupri | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2721887 | brensocatib 10 MG [Brinsupri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721888 | Brinsupri Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721889 | Brinsupri Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2721890 | brensocatib Oral Tablet [Brinsupri] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2721891 | Brinsupri 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721891 | Brinsupri 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721891 | Brinsupri 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721892 | brensocatib 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2721893 | brensocatib 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721893 | brensocatib 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2721894 | brensocatib 25 MG [Brinsupri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2721895 | Brinsupri 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2721895 | Brinsupri 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2721895 | Brinsupri 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2721930 | menthol 0.122 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2721931 | methyl salicylate 0.247 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2721932 | menthol 12.22 % / methyl salicylate 24.66 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2721932 | menthol 12.22 % / methyl salicylate 24.66 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2721932 | menthol 12.22 % / methyl salicylate 24.66 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2721934 | ketoconazole Soap Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2721935 | ketoconazole Medicated Bar Soap | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2721936 | ketoconazole 1 % Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2721936 | ketoconazole 1 % Medicated Bar Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2721936 | ketoconazole 1 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2721996 | telisotuzumab vedotin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 27220 | Hydroconchinine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27220 | Hydroconchinine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 27220 | Hydroconchinine | Designated preferred name (PT) | NO | |
| RxCUI: 27220 | Hydroconchinine | Full form of descriptor (FN) | NO | |
| RxCUI: 27221 | hydrotalcite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 27221 | hydrotalcite | Designated preferred name (PT) | YES | |
| RxCUI: 27221 | hydrotalcite | Full form of descriptor (FN) | YES | |
| RxCUI: 27221 | hydrotalcite | Designated preferred name (PT) | YES | |
| RxCUI: 27221 | hydrotalcite | Full form of descriptor (FN) | YES | |
| RxCUI: 2722187 | menthol 5 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722187 | menthol 5 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722187 | menthol 5 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722188 | menthol 5.1 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722188 | menthol 5.1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722188 | menthol 5.1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722189 | menthol 5 % / methyl salicylate 11 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722189 | menthol 5 % / methyl salicylate 11 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722189 | menthol 5 % / methyl salicylate 11 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2722217 | Prazimectin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2722218 | ivermectin 0.0187 MG/MG / praziquantel 0.14 MG/MG [Prazimectin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2722219 | Prazimectin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2722220 | Prazimectin Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2722221 | Prazimectin Oral Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2722222 | ivermectin / praziquantel Oral Paste [Prazimectin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2722223 | PraziMectin 1.87 % / 14.03 % Oral Paste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2722223 | PraziMectin 1.87 % / 14.03 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722223 | PraziMectin 1.87 % / 14.03 % Oral Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722225 | clotrimazole Vaginal Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2722226 | clotrimazole 1 % Vaginal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722226 | clotrimazole 1 % Vaginal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722226 | clotrimazole 1 % Vaginal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722265 | Restart | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2722266 | levonorgestrel 1.5 MG [Restart] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2722267 | Restart Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2722268 | Restart Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2722269 | levonorgestrel Oral Tablet [Restart] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2722270 | restart 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2722270 | restart 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722270 | restart 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722398 | rilzabrutinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2722399 | rilzabrutinib 400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 27224 | Hydroxyacylglutathione hydrolase | Designated preferred name (PT) | NO | |
| RxCUI: 27224 | Hydroxyacylglutathione hydrolase | Full form of descriptor (FN) | NO | |
| RxCUI: 2722400 | rilzabrutinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2722401 | rilzabrutinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2722402 | rilzabrutinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2722403 | rilzabrutinib 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722403 | rilzabrutinib 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2722404 | Wayrilz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2722405 | rilzabrutinib 400 MG [Wayrilz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2722406 | Wayrilz Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2722407 | Wayrilz Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2722408 | rilzabrutinib Oral Tablet [Wayrilz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2722409 | WAYRILZ 400 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2722409 | WAYRILZ 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722409 | WAYRILZ 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722410 | retatrutide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2722411 | nelarabine 375 MG in 75 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2722411 | nelarabine 375 MG in 75 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722411 | nelarabine 375 MG in 75 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722413 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 100 MG in 10 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 15 MG / doxylamine succinate 6.26 MG in 10 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2722413 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 100 MG in 10 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 15 MG / doxylamine succinate 6.26 MG in 10 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2722413 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 100 MG in 10 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 15 MG / doxylamine succinate 6.26 MG in 10 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722413 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 100 MG in 10 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 15 MG / doxylamine succinate 6.26 MG in 10 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722413 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 100 MG in 10 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 15 MG / doxylamine succinate 6.26 MG in 10 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2722414 | capsaicin 0.05 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722414 | capsaicin 0.05 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722414 | capsaicin 0.05 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722415 | menthol 91 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2722416 | menthol 9.1 % / methyl salicylate 29 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722416 | menthol 9.1 % / methyl salicylate 29 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722416 | menthol 9.1 % / methyl salicylate 29 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722417 | trolamine salicylate Medicated Patch | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2722418 | trolamine salicylate 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722418 | trolamine salicylate 10 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722418 | trolamine salicylate 10 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722418 | trolamine salicylate 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722419 | Salicor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2722420 | trolamine salicylate 0.1 MG/MG [Salicor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2722421 | Salicor Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2722422 | trolamine salicylate Medicated Patch [Salicor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2722423 | Salicor 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722423 | Salicor 10 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722423 | Salicor 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722423 | Salicor 10 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2722424 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2722425 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2722428 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-1273 OMICRON (LP.8.1) 0.25 ML Prefilled Syringe, 6m through 11y | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2722428 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-1273 OMICRON (LP.8.1) 0.25 ML Prefilled Syringe, 6m through 11y | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722428 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-1273 OMICRON (LP.8.1) 0.25 ML Prefilled Syringe, 6m through 11y | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722429 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) 0.1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722430 | Spikevax 2025-2026 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2722431 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) 0.1 MG/ML [Spikevax 2025-2026] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2722432 | Spikevax 2025-2026 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2722433 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Prefilled Syringe [Spikevax 2025-2026] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2722435 | spikevax 2025-2026 vaccine, 0.25 ML Prefilled Syringe, 6m through 11y | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2722435 | spikevax 2025-2026 vaccine, 0.25 ML Prefilled Syringe, 6m through 11y | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722435 | spikevax 2025-2026 vaccine, 0.25 ML Prefilled Syringe, 6m through 11y | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722435 | spikevax 2025-2026 vaccine, 0.25 ML Prefilled Syringe, 6m through 11y | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722436 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) 0.1 MG/ML Prefilled Syringe [Spikevax 2025-2026] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2722436 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1) 0.1 MG/ML Prefilled Syringe [Spikevax 2025-2026] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722437 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-1273 OMICRON (LP.8.1) 0.5 ML Prefilled Syringe, 12y+ | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2722437 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-1273 OMICRON (LP.8.1) 0.5 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722437 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-1273 OMICRON (LP.8.1) 0.5 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722438 | spikevax 2025-2026 vaccine, 0.5 ML Prefilled Syringe, 12y+ | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2722438 | spikevax 2025-2026 vaccine, 0.5 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722438 | spikevax 2025-2026 vaccine, 0.5 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722438 | spikevax 2025-2026 vaccine, 0.5 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722591 | benzalkonium chloride 0.05 % / ethanol 75 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722591 | benzalkonium chloride 0.05 % / ethanol 75 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722591 | benzalkonium chloride 0.05 % / ethanol 75 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722592 | salicylic acid 10.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2722593 | salicylic acid 1.08 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722593 | salicylic acid 1.08 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722593 | salicylic acid 1.08 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722594 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2722595 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2722598 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-BNT162b2 OMICRON (LP.8.1) 0.3 ML Prefilled Syringe, 12y+ | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2722598 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-BNT162b2 OMICRON (LP.8.1) 0.3 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722598 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-BNT162b2 OMICRON (LP.8.1) 0.3 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722599 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722600 | Comirnaty 2025-2026 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2722601 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.1 MG/ML [Comirnaty 2025-2026] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2722602 | Comirnaty 2025-2026 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2722603 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Prefilled Syringe [Comirnaty 2025-2026] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2722605 | COMIRNATY 2025-2026 vaccine, 0.3 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722605 | COMIRNATY 2025-2026 vaccine, 0.3 ML Prefilled Syringe, 12y+ | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2722605 | COMIRNATY 2025-2026 vaccine, 0.3 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722605 | COMIRNATY 2025-2026 vaccine, 0.3 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722606 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.1 MG/ML Prefilled Syringe [Comirnaty 2025-2026] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722606 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.1 MG/ML Prefilled Syringe [Comirnaty 2025-2026] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2722607 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.0333 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2722609 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-BNT162b2 OMICRON (LP.8.1) 0.3 ML Injection, 5y to < 12y | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2722609 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-BNT162b2 OMICRON (LP.8.1) 0.3 ML Injection, 5y to < 12y | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722609 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-BNT162b2 OMICRON (LP.8.1) 0.3 ML Injection, 5y to < 12y | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722610 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.0333 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722611 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.0333 MG/ML [Comirnaty 2025-2026] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2722612 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injection [Comirnaty 2025-2026] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2722614 | COMIRNATY 2025-2026 vaccine, 0.3 ML Injection, 5y to < 12y | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722614 | COMIRNATY 2025-2026 vaccine, 0.3 ML Injection, 5y to < 12y | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2722614 | COMIRNATY 2025-2026 vaccine, 0.3 ML Injection, 5y to < 12y | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722614 | COMIRNATY 2025-2026 vaccine, 0.3 ML Injection, 5y to < 12y | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722615 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.0333 MG/ML Injection [Comirnaty 2025-2026] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722615 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.0333 MG/ML Injection [Comirnaty 2025-2026] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2722617 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2722644 | beta-lactoglobulin (bovine) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2722645 | propylene glycol 0.005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2722646 | mineral oil 0.006 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2722647 | mineral oil / propylene glycol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2722648 | mineral oil / propylene glycol Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2722649 | mineral oil / propylene glycol Ophthalmic Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2722650 | propylene glycol 0.5 % / mineral oil 0.6 % Ophthalmic Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722650 | propylene glycol 0.5 % / mineral oil 0.6 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722650 | propylene glycol 0.5 % / mineral oil 0.6 % Ophthalmic Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722651 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2722654 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2722654 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722654 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722655 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.05 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722656 | Mnexspike 2025-2026 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2722657 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.05 MG/ML [Mnexspike 2025-2026] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2722658 | Mnexspike 2025-2026 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2722659 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Prefilled Syringe [Mnexspike 2025-2026] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2722661 | mNEXSPIKE 2025-2026 vaccine, 0.2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722661 | mNEXSPIKE 2025-2026 vaccine, 0.2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2722661 | mNEXSPIKE 2025-2026 vaccine, 0.2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722661 | mNEXSPIKE 2025-2026 vaccine, 0.2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722662 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.05 MG/ML Prefilled Syringe [Mnexspike 2025-2026] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722662 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.05 MG/ML Prefilled Syringe [Mnexspike 2025-2026] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2722666 | salicylic acid 17 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722666 | salicylic acid 17 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722666 | salicylic acid 17 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722931 | sodium fluoride 0.254 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2722931 | sodium fluoride 0.254 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722931 | sodium fluoride 0.254 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722931 | sodium fluoride 0.254 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722932 | acetaminophen 500 MG / dextromethorphan HBr 20 MG / pseudoephedrine HCl 60 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722932 | acetaminophen 500 MG / dextromethorphan HBr 20 MG / pseudoephedrine HCl 60 MG Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2722932 | acetaminophen 500 MG / dextromethorphan HBr 20 MG / pseudoephedrine HCl 60 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2722949 | ammonium carbonate 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2722950 | sodium carbonate 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2722951 | ammonium carbonate / sodium carbonate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2722952 | ammonium carbonate / sodium carbonate Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2722953 | ammonium carbonate / sodium carbonate Nasal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2722954 | ammonium carbonate / sodium carbonate Nasal Inhalant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2722955 | ammonium carbonate 15 % / sodium carbonate 10 % Nasal Inhalant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2722955 | ammonium carbonate 15 % / sodium carbonate 10 % Nasal Inhalant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2722955 | ammonium carbonate 15 % / sodium carbonate 10 % Nasal Inhalant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2722956 | creatine 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2722957 | creatine Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2722958 | creatine Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2722959 | creatine 1000 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2722959 | creatine 1000 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2722959 | creatine 1000 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723009 | Nuvaxovid 2025-2026 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2723010 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705 0.01 MG/ML [Nuvaxovid 2025-2026] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723011 | Nuvaxovid 2025-2026 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723012 | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein Prefilled Syringe [Nuvaxovid 2025-2026] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723014 | NUVAXOVID 2025-2026 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723014 | NUVAXOVID 2025-2026 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723014 | NUVAXOVID 2025-2026 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723015 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705 0.01 MG/ML Prefilled Syringe [Nuvaxovid 2025-2026] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723015 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705 0.01 MG/ML Prefilled Syringe [Nuvaxovid 2025-2026] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2723017 | Haberlea rhodopensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2723021 | acetaminophen 500 MG / dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723021 | acetaminophen 500 MG / dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723021 | acetaminophen 500 MG / dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723021 | acetaminophen 500 MG / dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723022 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723022 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2723022 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723022 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723022 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2723022 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723022 | acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2723023 | 1 daytime (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule) / 1 nighttime (acetaminophen 500 MG / dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2723023 | 1 daytime (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule) / 1 nighttime (acetaminophen 500 MG / dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule) | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2723023 | 1 daytime (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule) / 1 nighttime (acetaminophen 500 MG / dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723023 | 1 daytime (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule) / 1 nighttime (acetaminophen 500 MG / dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule) | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2723023 | 1 daytime (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule) / 1 nighttime (acetaminophen 500 MG / dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG / pseudoephedrine hydrochloride 30 MG Oral Capsule) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723024 | metoprolol tartrate 12.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723025 | metoprolol tartrate 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723025 | metoprolol tartrate 12.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723026 | metoprolol tartrate 12.5 MG [Lopressor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723027 | Lopressor 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723027 | Lopressor 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723027 | Lopressor 12.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723028 | Solovecin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2723029 | cefovecin 80 MG/ML [Solovecin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2723030 | Solovecin Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2723031 | cefovecin Injectable Solution [Solovecin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2723032 | Solovecin 80 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2723032 | Solovecin 80 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723032 | Solovecin 80 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723056 | sepiapterin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2723057 | sepiapterin 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723058 | sepiapterin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2723059 | sepiapterin Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2723060 | sepiapterin Oral Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2723061 | sepiapterin 1000 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723061 | sepiapterin 1000 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723062 | Sephience | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2723063 | sepiapterin 1000 MG [Sephience] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723064 | Sephience Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723065 | Sephience Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723066 | sepiapterin Oral Powder [Sephience] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723067 | Sephience 1000 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723067 | Sephience 1000 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723067 | Sephience 1000 MG Oral Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723068 | sepiapterin 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723069 | sepiapterin 250 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723069 | sepiapterin 250 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723070 | sepiapterin 250 MG [Sephience] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723071 | Sephience 250 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723071 | Sephience 250 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723071 | Sephience 250 MG Oral Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723100 | biotin 0.5 % / minoxidil 5 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723100 | biotin 0.5 % / minoxidil 5 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723100 | biotin 0.5 % / minoxidil 5 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723101 | cyclobenzaprine hydrochloride 2.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723102 | cyclobenzaprine Sublingual Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2723103 | cyclobenzaprine Sublingual Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2723106 | cyclobenzaprine hydrochloride 2.8 MG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723106 | cyclobenzaprine hydrochloride 2.8 MG Sublingual Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723106 | cyclobenzaprine hydrochloride 2.8 MG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723107 | Tonmya | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2723108 | cyclobenzaprine hydrochloride 2.8 MG [Tonmya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723109 | Tonmya Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723110 | Tonmya Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723111 | Tonmya Sublingual Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723112 | cyclobenzaprine Sublingual Tablet [Tonmya] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723114 | Tonmya 2.8 MG Sublingual Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723114 | Tonmya 2.8 MG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723114 | Tonmya 2.8 MG Sublingual Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723114 | Tonmya 2.8 MG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723115 | Lidocaine hydrochloride 20 mg/mL oromucosal spray | Designated preferred name (PT) | NO | |
| RxCUI: 2723115 | Lidocaine hydrochloride 20 mg/mL oromucosal spray | Full form of descriptor (FN) | NO | |
| RxCUI: 27232 | Hydroxybutyrate-dimer hydrolase | Designated preferred name (PT) | NO | |
| RxCUI: 27232 | Hydroxybutyrate-dimer hydrolase | Full form of descriptor (FN) | NO | |
| RxCUI: 2723216 | Odevixibat 200 microgram oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723216 | Odevixibat 200 microgram oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723217 | Odevixibat 600 microgram oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723217 | Odevixibat 600 microgram oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723218 | Product containing precisely sodium citrate 4 gram/1 sachet granules for conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2723218 | Product containing precisely sodium citrate 4 gram/1 sachet granules for conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2723219 | Ambroxol hydrochloride 6 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2723219 | Ambroxol hydrochloride 6 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2723220 | Azatadine maleate 100 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2723220 | Azatadine maleate 100 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2723221 | Lithium citrate 101.8 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2723221 | Lithium citrate 101.8 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2723222 | Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2723222 | Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2723223 | Potassium aminobenzoate 3 g powder for oral solution sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2723223 | Potassium aminobenzoate 3 g powder for oral solution sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723224 | Hexetidine 1 mg/mL oromucosal solution | Designated preferred name (PT) | NO | |
| RxCUI: 2723224 | Hexetidine 1 mg/mL oromucosal solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2723225 | Monobasic potassium phosphate 500 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723225 | Monobasic potassium phosphate 500 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723226 | Phenylephrine 2.5 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2723226 | Phenylephrine 2.5 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2723227 | Procyclidine hydrochloride 500 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2723227 | Procyclidine hydrochloride 500 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2723323 | Milophene | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2723324 | clomiphene citrate 50 MG [Milophene] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723324 | clomiphene citrate 50 MG [Milophene] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723325 | Milophene Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723326 | Milophene Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723327 | clomiphene Oral Tablet [Milophene] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723327 | clomiphene Oral Tablet [Milophene] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723328 | clomiphene citrate Oral Tablet [Milophene] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723329 | MiloPhene 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723329 | MiloPhene 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723329 | MiloPhene 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723329 | MiloPhene 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723331 | risankizumab-rzaa 180 MG in 1.2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723331 | risankizumab-rzaa 180 MG in 1.2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723331 | risankizumab-rzaa 180 MG in 1.2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723332 | Skyrizi 180 MG in 1.2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723332 | Skyrizi 180 MG in 1.2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723332 | Skyrizi 180 MG in 1.2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723334 | denosumab-nxxp | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2723335 | denosumab-nxxp 70 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723338 | denosumab-nxxp 120 MG in 1.7 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723338 | denosumab-nxxp 120 MG in 1.7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723338 | denosumab-nxxp 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723339 | denosumab-nxxp 70 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723339 | denosumab-nxxp 70 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723340 | Bilprevda | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2723341 | denosumab-nxxp 70 MG/ML [Bilprevda] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723342 | Bilprevda Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723343 | denosumab Injection [Bilprevda] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723345 | BILPREVDA 120 MG in 1.7 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723345 | BILPREVDA 120 MG in 1.7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723345 | BILPREVDA 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723346 | BILPREVDA 70 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723346 | BILPREVDA 70 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723346 | BILPREVDA 70 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2723347 | Chlorhexidine digluconate 2.5 mg/g and phenol 12 mg/g cutaneous cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723347 | Chlorhexidine digluconate 2.5 mg/g and phenol 12 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2723347 | Chlorhexidine digluconate 2.5 mg/g and phenol 12 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2723348 | denosumab-nxxp 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723350 | denosumab-nxxp 60 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723350 | denosumab-nxxp 60 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723350 | denosumab-nxxp 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723351 | denosumab-nxxp 60 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723351 | denosumab-nxxp 60 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723352 | Bildyos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2723353 | denosumab-nxxp 60 MG/ML [Bildyos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723354 | Bildyos Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723355 | denosumab Prefilled Syringe [Bildyos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723357 | BILDYOS 60 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723357 | BILDYOS 60 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723357 | BILDYOS 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723358 | BILDYOS 60 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723358 | BILDYOS 60 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723358 | BILDYOS 60 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2723359 | Clotrimazole 10 mg/g and hydrocortisone (as hydrocortisone acetate) 10 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2723359 | Clotrimazole 10 mg/g and hydrocortisone (as hydrocortisone acetate) 10 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2723360 | zopapogene imadenovec-drba | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2723361 | zopapogene imadenovec | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2723362 | zopapogene imadenovec-drba 500000000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723363 | zopapogene imadenovec Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2723364 | zopapogene imadenovec Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2723367 | zopapogene imadenovec-drba 500,000,000,000 PU in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723367 | zopapogene imadenovec-drba 500,000,000,000 PU in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723367 | zopapogene imadenovec-drba 500,000,000,000 PU in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723368 | zopapogene imadenovec-drba 500000000000 UNT/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723368 | zopapogene imadenovec-drba 500000000000 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723369 | Papzimeos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2723370 | zopapogene imadenovec-drba 500000000000 UNT/ML [Papzimeos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723371 | Papzimeos Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723372 | zopapogene imadenovec Injection [Papzimeos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723374 | Papzimeos 500,000,000,000 PU in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723374 | Papzimeos 500,000,000,000 PU in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723374 | Papzimeos 500,000,000,000 PU in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723375 | Papzimeos 500,000,000,000 UNT/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723375 | Papzimeos 500,000,000,000 UNT/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723375 | Papzimeos 500,000,000,000 UNT/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2723376 | Colloid sulfur 80 mg/g and resorcinol 20 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2723376 | Colloid sulfur 80 mg/g and resorcinol 20 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2723377 | pegloticase 0.16 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723378 | pegloticase 8 MG in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723378 | pegloticase 8 MG in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723378 | pegloticase 8 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723379 | pegloticase 0.16 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723379 | pegloticase 0.16 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723380 | pegloticase 0.16 MG/ML [Krystexxa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723381 | KRYSTEXXA 8 MG in 50 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723381 | KRYSTEXXA 8 MG in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723381 | KRYSTEXXA 8 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723382 | KRYSTEXXA 0.16 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723382 | KRYSTEXXA 0.16 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723382 | KRYSTEXXA 0.16 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2723383 | gemcitabine 225 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723384 | gemcitabine Drug Implant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2723385 | gemcitabine Drug Implant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2723386 | gemcitabine 225 MG Intravesical System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723386 | gemcitabine 225 MG Intravesical System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723386 | gemcitabine 225 MG Intravesical System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723387 | Inlexzo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2723388 | gemcitabine 225 MG [Inlexzo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723389 | Inlexzo Drug Implant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723390 | gemcitabine Drug Implant [Inlexzo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723391 | inlexzo 225 MG Intravesical System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723391 | inlexzo 225 MG Intravesical System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723391 | inlexzo 225 MG Intravesical System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723394 | Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2723394 | Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2723395 | chlorhexidine gluconate 1.2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723395 | chlorhexidine gluconate 1.2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723395 | chlorhexidine gluconate 1.2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723396 | Betamethasone (as betamethasone valerate) 250 microgram/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2723396 | Betamethasone (as betamethasone valerate) 250 microgram/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2723399 | Vabrinty 30 MG in 0.5 ML (4 month) Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723399 | Vabrinty 30 MG in 0.5 ML (4 month) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723399 | Vabrinty 30 MG in 0.5 ML (4 month) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723400 | Chlorhexidine hydrochloride 1 mg/g and neomycin sulfate 5 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2723400 | Chlorhexidine hydrochloride 1 mg/g and neomycin sulfate 5 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2723401 | Benzoyl peroxide 50 mg/g and potassium hydroxyquinoline sulfate 5 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2723401 | Benzoyl peroxide 50 mg/g and potassium hydroxyquinoline sulfate 5 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2723403 | lecanemab-irmb 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723404 | lecanemab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2723406 | lecanemab-irmb 360 MG in 1.8 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723406 | lecanemab-irmb 360 MG in 1.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723406 | lecanemab-irmb 360 MG in 1.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723407 | lecanemab-irmb 200 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723407 | lecanemab-irmb 200 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723408 | lecanemab-irmb 200 MG/ML [Leqembi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723409 | lecanemab Auto-Injector [Leqembi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723411 | LEQEMBI IQLIK 360 MG in 1.8 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723411 | LEQEMBI IQLIK 360 MG in 1.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723411 | LEQEMBI IQLIK 360 MG in 1.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723412 | LEQEMBI IQLIK 200 MG/ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2723412 | LEQEMBI IQLIK 200 MG/ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723412 | LEQEMBI IQLIK 200 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723413 | Benzoyl peroxide 100 mg/g and potassium hydroxyquinoline sulfate 5 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2723413 | Benzoyl peroxide 100 mg/g and potassium hydroxyquinoline sulfate 5 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2723445 | Tiotixene hydrochloride 5 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723445 | Tiotixene hydrochloride 5 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723445 | Tiotixene hydrochloride 5 mg oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723446 | apremilast 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723447 | apremilast Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2723448 | apremilast 75 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723448 | apremilast 75 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723448 | apremilast 75 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723449 | apremilast 75 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723450 | apremilast 75 MG [Otezla] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723451 | apremilast Extended Release Oral Tablet [Otezla] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723452 | Otezla XR 75 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723452 | Otezla XR 75 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723452 | Otezla XR 75 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723453 | apremilast 75 MG Extended Release Oral Tablet [Otezla] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2723453 | apremilast 75 MG Extended Release Oral Tablet [Otezla] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723454 | Chlorphenamine 12 mg oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723454 | Chlorphenamine 12 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723454 | Chlorphenamine 12 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723455 | Tiotixene hydrochloride 10 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723455 | Tiotixene hydrochloride 10 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723455 | Tiotixene hydrochloride 10 mg oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723456 | Product containing precisely sevelamer 400 milligram/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2723456 | Product containing precisely sevelamer 400 milligram/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2723457 | Product containing precisely tetracycline 100 milligram/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2723457 | Product containing precisely tetracycline 100 milligram/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2723458 | Phenylpropanolamine 75 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723458 | Phenylpropanolamine 75 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723459 | Brompheniramine 12 mg and pseudoephedrine hydrochloride 120 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723459 | Brompheniramine 12 mg and pseudoephedrine hydrochloride 120 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723460 | Glucosamine 500 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723460 | Glucosamine 500 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723461 | Tiotixene hydrochloride 1 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723461 | Tiotixene hydrochloride 1 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723461 | Tiotixene hydrochloride 1 mg oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723462 | Diphenhydramine 38 mg and ibuprofen 200 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723462 | Diphenhydramine 38 mg and ibuprofen 200 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723463 | Tiotixene hydrochloride 2 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723463 | Tiotixene hydrochloride 2 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723463 | Tiotixene hydrochloride 2 mg oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723464 | Elagolix sodium 300 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723464 | Elagolix sodium 300 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723465 | Clodronate disodium 400 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723465 | Clodronate disodium 400 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723466 | Tiotixene hydrochloride 20 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723466 | Tiotixene hydrochloride 20 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723466 | Tiotixene hydrochloride 20 mg oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723467 | Elagolix sodium 300 mg and estradiol 1 mg and norethisterone 500 microgram oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723467 | Elagolix sodium 300 mg and estradiol 1 mg and norethisterone 500 microgram oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723467 | Elagolix sodium 300 mg and estradiol 1 mg and norethisterone 500 microgram oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2723485 | hypromellose 0.2 % Ophthalmic Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723485 | hypromellose 0.2 % Ophthalmic Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723485 | hypromellose 0.2 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723486 | Omega-3-acid ethyl esters 90 1 g oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2723486 | Omega-3-acid ethyl esters 90 1 g oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 27235 | Hydroxycinnamoyl coenzyme A-quinate transferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27235 | Hydroxycinnamoyl coenzyme A-quinate transferase | Designated preferred name (PT) | NO | |
| RxCUI: 27235 | Hydroxycinnamoyl coenzyme A-quinate transferase | Full form of descriptor (FN) | NO | |
| RxCUI: 2723544 | Framycetin sulfate 5 mg/mL eye drops | Designated preferred name (PT) | NO | |
| RxCUI: 2723544 | Framycetin sulfate 5 mg/mL eye drops | Full form of descriptor (FN) | NO | |
| RxCUI: 2723545 | Prednisolone acetate 10 mg/mL eye drops | Designated preferred name (PT) | NO | |
| RxCUI: 2723545 | Prednisolone acetate 10 mg/mL eye drops | Full form of descriptor (FN) | NO | |
| RxCUI: 2723546 | Edetate disodium 3.7 mg/g eye drops | Designated preferred name (PT) | NO | |
| RxCUI: 2723546 | Edetate disodium 3.7 mg/g eye drops | Full form of descriptor (FN) | NO | |
| RxCUI: 2723547 | Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723547 | Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723548 | Allylestrenol micronised 5 mg oral tablet | British preferred term (PTGB) | NO | |
| RxCUI: 2723548 | Allylestrenol micronised 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723548 | Allylestrenol micronised 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723549 | Abacavir (as abacavir hydrochloride) 600 mg and lamivudine 300 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723549 | Abacavir (as abacavir hydrochloride) 600 mg and lamivudine 300 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723550 | Cefuroxime axetil 300 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723550 | Cefuroxime axetil 300 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723551 | Norethisterone 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723551 | Norethisterone 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723551 | Norethisterone 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723552 | Clodronate disodium 520 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723552 | Clodronate disodium 520 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723554 | Product containing precisely zofenopril calcium 7.5 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2723554 | Product containing precisely zofenopril calcium 7.5 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2723555 | Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723555 | Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723556 | Monobasic sodium phosphate 1.5 g oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723556 | Monobasic sodium phosphate 1.5 g oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723557 | Product containing precisely zofenopril calcium 30 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2723557 | Product containing precisely zofenopril calcium 30 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2723561 | Hydrochlorothiazide 12.5 mg and irbesartan (as irbesartan hydrochloride) 300 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723561 | Hydrochlorothiazide 12.5 mg and irbesartan (as irbesartan hydrochloride) 300 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723562 | docosahexaenoic acid algal oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2723563 | Exaprin Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2723564 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG [Exaprin Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2723565 | Exaprin Plus Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2723566 | Exaprin Plus Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2723567 | acetaminophen / aspirin / caffeine Oral Tablet [Exaprin Plus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2723568 | Exaprin Plus 250 MG / 250 MG / 65 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2723568 | Exaprin Plus 250 MG / 250 MG / 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723568 | Exaprin Plus 250 MG / 250 MG / 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723568 | Exaprin Plus 250 MG / 250 MG / 65 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723569 | Exaprin Extra Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2723570 | aspirin 500 MG / caffeine 32.5 MG [Exaprin Extra Strength] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2723571 | Exaprin Extra Strength Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2723572 | Exaprin Extra Strength Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2723573 | aspirin / caffeine Oral Tablet [Exaprin Extra Strength] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2723574 | Exaprin Extra Strength 500 MG / 32.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723574 | Exaprin Extra Strength 500 MG / 32.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2723574 | Exaprin Extra Strength 500 MG / 32.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723574 | Exaprin Extra Strength 500 MG / 32.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723575 | Liomny | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2723576 | liothyronine sodium 0.025 MG [Liomny] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723577 | Liomny Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723578 | Liomny Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723579 | liothyronine Oral Tablet [Liomny] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723581 | LIOMNY 25 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723581 | LIOMNY 25 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723581 | LIOMNY 25 MCG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723582 | liothyronine sodium 0.05 MG [Liomny] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723583 | LIOMNY 50 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723583 | LIOMNY 50 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723583 | LIOMNY 50 MCG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723584 | liothyronine sodium 0.005 MG [Liomny] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723585 | LIOMNY 5 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723585 | LIOMNY 5 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723585 | LIOMNY 5 MCG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723586 | Drospirenone 3 mg and ethinylestradiol (as ethinylestradiol betadex clathrate) 20 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723586 | Drospirenone 3 mg and ethinylestradiol (as ethinylestradiol betadex clathrate) 20 microgram oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723586 | Drospirenone 3 mg and ethinylestradiol (as ethinylestradiol betadex clathrate) 20 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723587 | Cyproterone acetate 50 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723587 | Cyproterone acetate 50 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723588 | Midazolam (as midazolam maleate) 7.5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723588 | Midazolam (as midazolam maleate) 7.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723589 | Methylcellulose-450 500 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723589 | Methylcellulose-450 500 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723590 | Oxymorphone 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723590 | Oxymorphone 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723591 | Orciprenaline 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723591 | Orciprenaline 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723591 | Orciprenaline 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723592 | Doxylamine 25 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723592 | Doxylamine 25 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723593 | Ethinylestradiol 10 microgram and norethisterone 1 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723593 | Ethinylestradiol 10 microgram and norethisterone 1 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723593 | Ethinylestradiol 10 microgram and norethisterone 1 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723594 | Product containing precisely methionine 250 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2723594 | Product containing precisely methionine 250 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2723595 | Estradiol valerate 2 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723595 | Estradiol valerate 2 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723596 | Diltiazem maleate 120 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723596 | Diltiazem maleate 120 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723597 | Oxymorphone 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723597 | Oxymorphone 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723598 | Moracizine 250 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723598 | Moracizine 250 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723598 | Moracizine 250 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723599 | Moracizine 300 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723599 | Moracizine 300 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723599 | Moracizine 300 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723600 | Pafuramidine maleate 100 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723600 | Pafuramidine maleate 100 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723601 | Product containing precisely trimetazidine hydrochloride 20 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2723601 | Product containing precisely trimetazidine hydrochloride 20 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2723602 | Product containing precisely sitagliptin (as sitagliptin hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2723602 | Product containing precisely sitagliptin (as sitagliptin hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2723603 | Drospirenone 2 mg and estradiol 1 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723603 | Drospirenone 2 mg and estradiol 1 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723604 | Hyoscyamine 150 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723604 | Hyoscyamine 150 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723605 | Quinine sulfate 300 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723605 | Quinine sulfate 300 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723606 | Product containing precisely methionine 100 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2723606 | Product containing precisely methionine 100 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2723607 | Norethisterone 1 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723607 | Norethisterone 1 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723607 | Norethisterone 1 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723609 | Paracetamol 325 mg and tramadol 37.5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723609 | Paracetamol 325 mg and tramadol 37.5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723609 | Paracetamol 325 mg and tramadol 37.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723650 | selumetinib 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723651 | selumetinib Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2723652 | selumetinib Oral Granules | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2723653 | selumetinib 5 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723653 | selumetinib 5 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723654 | selumetinib 5 MG [Koselugo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723655 | Koselugo Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723656 | selumetinib Oral Granules [Koselugo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723657 | Koselugo 5 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723657 | Koselugo 5 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723657 | Koselugo 5 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723658 | selumetinib 7.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723659 | selumetinib 7.5 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723659 | selumetinib 7.5 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723660 | selumetinib 7.5 MG [Koselugo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723661 | Koselugo 7.5 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723661 | Koselugo 7.5 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723661 | Koselugo 7.5 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723662 | Chlorphenamine maleate 8 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723662 | Chlorphenamine maleate 8 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723662 | Chlorphenamine maleate 8 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723663 | DOCEtaxel 80 MG Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2723663 | DOCEtaxel 80 MG Kit | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723663 | DOCEtaxel 80 MG Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723663 | DOCEtaxel 80 MG Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723663 | DOCEtaxel 80 MG Kit | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723664 | BEIZRAY 80 MG Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2723664 | BEIZRAY 80 MG Kit | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723664 | BEIZRAY 80 MG Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723664 | BEIZRAY 80 MG Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723665 | DOCEtaxel 160 MG Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2723665 | DOCEtaxel 160 MG Kit | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723665 | DOCEtaxel 160 MG Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723665 | DOCEtaxel 160 MG Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723665 | DOCEtaxel 160 MG Kit | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723666 | BEIZRAY 160 MG Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2723666 | BEIZRAY 160 MG Kit | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723666 | BEIZRAY 160 MG Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723666 | BEIZRAY 160 MG Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723667 | Conjugated estrogen 625 microgram and medroxyprogesterone 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723667 | Conjugated estrogen 625 microgram and medroxyprogesterone 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723668 | Product containing precisely pyridostigmine 30 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2723668 | Product containing precisely pyridostigmine 30 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2723669 | Tetracycline 500 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723669 | Tetracycline 500 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723707 | tizanidine 8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723707 | tizanidine 8 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723708 | tiZANidine 8 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723708 | tiZANidine 8 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723708 | tiZANidine 8 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723708 | tiZANidine 8 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723708 | tiZANidine 8 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723709 | tizanidine 8 MG [Zanaflex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723709 | tizanidine 8 MG [Zanaflex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723710 | Zanaflex 8 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723710 | Zanaflex 8 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723710 | Zanaflex 8 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723710 | Zanaflex 8 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723710 | Zanaflex 8 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723710 | Zanaflex 8 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723711 | zinc undecylenate 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2723712 | undecylenic acid 10 % / zinc undecylenate 12 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723712 | undecylenic acid 10 % / zinc undecylenate 12 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723712 | undecylenic acid 10 % / zinc undecylenate 12 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723713 | mineral oil, light 0.006 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2723714 | mineral oil / mineral oil, light Ophthalmic Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2723715 | mineral oil 0.6 % / mineral oil, light 0.6 % Ophthalmic Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723715 | mineral oil 0.6 % / mineral oil, light 0.6 % Ophthalmic Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723715 | mineral oil 0.6 % / mineral oil, light 0.6 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723716 | cetylpyridinium chloride 0.0006 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2723717 | cetylpyridinium Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2723718 | cetylpyridinium Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2723721 | cetylpyridinium chloride 0.06 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723721 | cetylpyridinium chloride 0.06 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2723721 | cetylpyridinium chloride 0.06 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2723722 | Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723722 | Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723751 | Guanethidine monosulfate 25 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2723751 | Guanethidine monosulfate 25 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2723752 | berahyaluronidase alfa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2723753 | pembrolizumab-pmph | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2723754 | pembrolizumab-pmph 165 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723755 | berahyaluronidase alfa-pmph | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2723756 | berahyaluronidase alfa-pmph 2000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2723757 | berahyaluronidase alfa / pembrolizumab | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2723758 | berahyaluronidase alfa / pembrolizumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2723759 | berahyaluronidase alfa / pembrolizumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2723762 | pembrolizumab-pmph 395 MG / berahyaluronidase alfa-pmph 4800 UNT in 2.4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723762 | pembrolizumab-pmph 395 MG / berahyaluronidase alfa-pmph 4800 UNT in 2.4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723762 | pembrolizumab-pmph 395 MG / berahyaluronidase alfa-pmph 4800 UNT in 2.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723763 | berahyaluronidase alfa-pmph 2000 UNT/ML / pembrolizumab-pmph 165 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723764 | Keytruda Qlex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2723765 | berahyaluronidase alfa-pmph 2000 UNT/ML / pembrolizumab-pmph 165 MG/ML [Keytruda Qlex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723766 | Keytruda Qlex Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723767 | berahyaluronidase alfa / pembrolizumab Injection [Keytruda Qlex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723769 | Keytruda Qlex 395 MG / 4800 UNT in 2.4 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723769 | Keytruda Qlex 395 MG / 4800 UNT in 2.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723769 | Keytruda Qlex 395 MG / 4800 UNT in 2.4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723770 | berahyaluronidase alfa-pmph 2000 UNT/ML / pembrolizumab-pmph 165 MG/ML Injection [Keytruda Qlex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2723771 | pembrolizumab-pmph 790 MG / berahyaluronidase alfa-pmph 9600 UNT in 4.8 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723771 | pembrolizumab-pmph 790 MG / berahyaluronidase alfa-pmph 9600 UNT in 4.8 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723771 | pembrolizumab-pmph 790 MG / berahyaluronidase alfa-pmph 9600 UNT in 4.8 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723772 | Keytruda Qlex 790 MG / 9600 UNT in 4.8 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723772 | Keytruda Qlex 790 MG / 9600 UNT in 4.8 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723772 | Keytruda Qlex 790 MG / 9600 UNT in 4.8 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723903 | Aagylur | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2723904 | penicillamine 250 MG [Aagylur] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2723904 | penicillamine 250 MG [Aagylur] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723905 | Aagylur Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723906 | Aagylur Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2723907 | penicillamine Oral Capsule [Aagylur] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2723907 | penicillamine Oral Capsule [Aagylur] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723908 | AAGYLUR 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723908 | AAGYLUR 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723908 | AAGYLUR 250 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2723908 | AAGYLUR 250 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2723912 | ketamine Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2723913 | ketamine 100 MG in 10 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2723913 | ketamine 100 MG in 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723913 | ketamine 100 MG in 10 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723914 | ketamine 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2723916 | remestemcel-L-rknd Kit Patient Weight 100 - < 112.5 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2723916 | remestemcel-L-rknd Kit Patient Weight 100 - < 112.5 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723916 | remestemcel-L-rknd Kit Patient Weight 100 - < 112.5 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723917 | Ryoncil Kit Patient Weight 100 - < 112.5 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2723917 | Ryoncil Kit Patient Weight 100 - < 112.5 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723917 | Ryoncil Kit Patient Weight 100 - < 112.5 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723918 | remestemcel-L-rknd Kit Patient Weight 112.5 - < 125 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2723918 | remestemcel-L-rknd Kit Patient Weight 112.5 - < 125 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723918 | remestemcel-L-rknd Kit Patient Weight 112.5 - < 125 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723919 | Ryoncil Kit Patient Weight 112.5 - < 125 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2723919 | Ryoncil Kit Patient Weight 112.5 - < 125 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723919 | Ryoncil Kit Patient Weight 112.5 - < 125 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723920 | remestemcel-L-rknd Kit Patient Weight 125 - < 137.5 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2723920 | remestemcel-L-rknd Kit Patient Weight 125 - < 137.5 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723920 | remestemcel-L-rknd Kit Patient Weight 125 - < 137.5 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723921 | Ryoncil Kit Patient Weight 125 - < 137.5 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2723921 | Ryoncil Kit Patient Weight 125 - < 137.5 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723921 | Ryoncil Kit Patient Weight 125 - < 137.5 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723922 | remestemcel-L-rknd Kit Patient Weight 137.5 - < 150 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2723922 | remestemcel-L-rknd Kit Patient Weight 137.5 - < 150 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723922 | remestemcel-L-rknd Kit Patient Weight 137.5 - < 150 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2723923 | Ryoncil Kit Patient Weight 137.5 - < 150 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2723923 | Ryoncil Kit Patient Weight 137.5 - < 150 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2723923 | Ryoncil Kit Patient Weight 137.5 - < 150 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724016 | Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2724016 | Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2724018 | Lovastatin 20 mg and niacin 1 g oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2724018 | Lovastatin 20 mg and niacin 1 g oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2724019 | Lovastatin 20 mg and nicotinic acid 1 g oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2724022 | Hydrochlorothiazide 12.5 mg and metoprolol tartrate 25 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2724022 | Hydrochlorothiazide 12.5 mg and metoprolol tartrate 25 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2724024 | Lovastatin 20 mg and niacin 500 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2724024 | Lovastatin 20 mg and niacin 500 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2724025 | Lovastatin 20 mg and nicotinic acid 500 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2724027 | Potassium citrate 1.08 g oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2724027 | Potassium citrate 1.08 g oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2724028 | Lovastatin 20 mg and niacin 750 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2724028 | Lovastatin 20 mg and niacin 750 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2724029 | Lovastatin 20 mg and nicotinic acid 750 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2724032 | Product containing precisely theophylline anhydrous 200 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2724032 | Product containing precisely theophylline anhydrous 200 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2724033 | Diltiazem maleate 219 mg and enalapril maleate 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2724033 | Diltiazem maleate 219 mg and enalapril maleate 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2724036 | Hydrochlorothiazide 12.5 mg and metoprolol tartrate 100 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2724036 | Hydrochlorothiazide 12.5 mg and metoprolol tartrate 100 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2724037 | Hydrochlorothiazide 12.5 mg and metoprolol tartrate 50 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2724037 | Hydrochlorothiazide 12.5 mg and metoprolol tartrate 50 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2724039 | Potassium citrate 540 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2724039 | Potassium citrate 540 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2724042 | Ranolazine 500 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2724042 | Ranolazine 500 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2724361 | donidalorsen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2724362 | donidalorsen sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2724363 | paltusotine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2724364 | paltusotine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2724365 | remibrutinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2724366 | apremilast starter pack 10 MG (4), 20 MG (4), 30 MG (19), 75 MG XR (14) Oral Tablet 28-Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2724366 | apremilast starter pack 10 MG (4), 20 MG (4), 30 MG (19), 75 MG XR (14) Oral Tablet 28-Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724366 | apremilast starter pack 10 MG (4), 20 MG (4), 30 MG (19), 75 MG XR (14) Oral Tablet 28-Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724367 | Otezla 28-Day 10/20/30/75 Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2724367 | Otezla 28-Day 10/20/30/75 Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724367 | Otezla 28-Day 10/20/30/75 Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724369 | certolizumab pegol 200 MG in 1 ML Prefilled Syringe, 2 count | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2724369 | certolizumab pegol 200 MG in 1 ML Prefilled Syringe, 2 count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724369 | certolizumab pegol 200 MG in 1 ML Prefilled Syringe, 2 count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724370 | Cimzia Prefilled Syringe, 2 count | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2724370 | Cimzia Prefilled Syringe, 2 count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724370 | Cimzia Prefilled Syringe, 2 count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724371 | certolizumab pegol 200 MG in 1 ML Prefilled Syringe, 6 count | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2724371 | certolizumab pegol 200 MG in 1 ML Prefilled Syringe, 6 count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724371 | certolizumab pegol 200 MG in 1 ML Prefilled Syringe, 6 count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724372 | Cimzia Starter Kit, 6 count | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2724372 | Cimzia Starter Kit, 6 count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724372 | Cimzia Starter Kit, 6 count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724375 | Uripropamine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2724376 | phenylpropanolamine hydrochloride 50 MG [Uripropamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2724377 | Uripropamine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2724378 | Uripropamine Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2724379 | Uripropamine Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2724380 | phenylpropanolamine Chewable Tablet [Uripropamine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2724382 | UriPropamine 50 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2724382 | UriPropamine 50 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2724382 | UriPropamine 50 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2724383 | phenylpropanolamine hydrochloride 75 MG [Uripropamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2724384 | UriPropamine 75 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2724384 | UriPropamine 75 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2724384 | UriPropamine 75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2724385 | phenylpropanolamine hydrochloride 25 MG [Uripropamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2724386 | UriPropamine 25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2724386 | UriPropamine 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2724386 | UriPropamine 25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2724388 | remibrutinib 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2724389 | remibrutinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2724390 | remibrutinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2724391 | remibrutinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2724392 | remibrutinib 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724392 | remibrutinib 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2724393 | Rhapsido | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2724394 | remibrutinib 25 MG [Rhapsido] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2724395 | Rhapsido Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2724396 | Rhapsido Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2724397 | remibrutinib Oral Tablet [Rhapsido] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2724398 | Rhapsido 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2724398 | Rhapsido 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724398 | Rhapsido 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724399 | paltusotine 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 27244 | Hyetellose-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 27244 | Hyetellose-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 27244 | Hyetellose-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 27244 | Hyetellose-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 27244 | Hyetellose-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 27244 | Hyetellose-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 27244 | Hyetellose-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 27244 | Hyetellose-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 2724400 | paltusotine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2724401 | paltusotine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2724402 | paltusotine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2724403 | paltusotine 20 MG Oral Tablet, Once Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724403 | paltusotine 20 MG Oral Tablet, Once Daily | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2724403 | paltusotine 20 MG Oral Tablet, Once Daily | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724404 | Palsonify | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2724405 | paltusotine 20 MG [Palsonify] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2724406 | Palsonify Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2724407 | Palsonify Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2724408 | paltusotine Oral Tablet [Palsonify] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2724409 | Palsonify 20 MG Oral Tablet, Once Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724409 | Palsonify 20 MG Oral Tablet, Once Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724409 | Palsonify 20 MG Oral Tablet, Once Daily | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724409 | Palsonify 20 MG Oral Tablet, Once Daily | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2724410 | paltusotine 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2724411 | paltusotine 30 MG Oral Tablet, Once Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724411 | paltusotine 30 MG Oral Tablet, Once Daily | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2724411 | paltusotine 30 MG Oral Tablet, Once Daily | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724412 | paltusotine 30 MG [Palsonify] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2724413 | Palsonify 30 MG Oral Tablet, Once Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724413 | Palsonify 30 MG Oral Tablet, Once Daily | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724413 | Palsonify 30 MG Oral Tablet, Once Daily | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724413 | Palsonify 30 MG Oral Tablet, Once Daily | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2724414 | chlorpheniramine maleate 0.35 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2724415 | chlorpheniramine maleate 3.5 MG / phenylephrine hydrochloride 10 MG in 10 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2724415 | chlorpheniramine maleate 3.5 MG / phenylephrine hydrochloride 10 MG in 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724415 | chlorpheniramine maleate 3.5 MG / phenylephrine hydrochloride 10 MG in 10 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724415 | chlorpheniramine maleate 3.5 MG / phenylephrine hydrochloride 10 MG in 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724416 | Dulcolax Osmotic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2724417 | polyethylene glycol 3350 17000 MG [Dulcolax Osmotic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2724418 | Dulcolax Osmotic Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2724419 | Dulcolax Osmotic Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2724420 | polyethylene glycol 3350 Powder for Oral Solution [Dulcolax Osmotic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2724421 | Dulcolax Osmotic 17 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2724421 | Dulcolax Osmotic 17 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2724421 | Dulcolax Osmotic 17 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2724421 | Dulcolax Osmotic 17 GM Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2724422 | copper 1.75 SQCM | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2724423 | copper 1.75 SQCM Intrauterine Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2724423 | copper 1.75 SQCM Intrauterine Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724423 | copper 1.75 SQCM Intrauterine Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724424 | Miudella | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2724425 | copper 1.75 SQCM [Miudella] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2724426 | Miudella Drug Implant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2724427 | copper Drug Implant [Miudella] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2724428 | Miudella 1.75 SQCM Intrauterine Implant | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2724428 | Miudella 1.75 SQCM Intrauterine Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724428 | Miudella 1.75 SQCM Intrauterine Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724428 | Miudella 1.75 SQCM Intrauterine Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724429 | ustekinumab-aauz 45 MG in 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2724429 | ustekinumab-aauz 45 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724429 | ustekinumab-aauz 45 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724430 | ustekinumab-aauz 90 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2724431 | Otulfi 45 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724431 | Otulfi 45 MG in 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2724431 | Otulfi 45 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724431 | Otulfi 45 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724432 | ustekinumab-aauz 90 MG/ML Injection [Otulfi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2724432 | ustekinumab-aauz 90 MG/ML Injection [Otulfi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2724433 | bumetanide 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2724434 | bumetanide Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2724435 | bumetanide Nasal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2724436 | bumetanide Nasal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2724437 | bumetanide 0.5 MG in 0.1 ML Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724437 | bumetanide 0.5 MG in 0.1 ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724437 | bumetanide 0.5 MG in 0.1 ML Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2724438 | Enbumyst | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2724439 | bumetanide 5 MG/ML [Enbumyst] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2724440 | Enbumyst Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2724441 | Enbumyst Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2724442 | bumetanide Nasal Spray [Enbumyst] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2724443 | Enbumyst 0.5 MG in 0.1 ML Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2724443 | Enbumyst 0.5 MG in 0.1 ML Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724443 | Enbumyst 0.5 MG in 0.1 ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724444 | donidalorsen 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2724445 | donidalorsen Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2724446 | donidalorsen Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2724447 | donidalorsen 80 MG in 0.8 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2724447 | donidalorsen 80 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724447 | donidalorsen 80 MG in 0.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724448 | donidalorsen 100 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2724448 | donidalorsen 100 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2724449 | Dawnzera | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2724450 | donidalorsen 100 MG/ML [Dawnzera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2724451 | Dawnzera Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2724452 | donidalorsen Auto-Injector [Dawnzera] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2724453 | DAWNZERA 80 MG in 0.8 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2724453 | DAWNZERA 80 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724453 | DAWNZERA 80 MG in 0.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724453 | DAWNZERA 80 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2724454 | DAWNZERA 100 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2724454 | DAWNZERA 100 MG/ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2724454 | DAWNZERA 100 MG/ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2724455 | Gamrozyne | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2724456 | gamithromycin 150 MG/ML [Gamrozyne] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2724457 | Gamrozyne Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2724458 | gamithromycin Injectable Solution [Gamrozyne] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2724459 | GAMROZYNE 150 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2724459 | GAMROZYNE 150 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2724459 | GAMROZYNE 150 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2724460 | lamotrigine 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2724460 | lamotrigine 10 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2724461 | lamotrigine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2724461 | lamotrigine Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2724462 | lamoTRIgine 10 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724462 | lamoTRIgine 10 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2724462 | lamoTRIgine 10 MG/mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2724463 | lamotrigine 10 MG/ML [Subvenite] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2724463 | lamotrigine 10 MG/ML [Subvenite] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2724464 | Subvenite Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2724465 | lamotrigine Oral Suspension [Subvenite] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2724465 | lamotrigine Oral Suspension [Subvenite] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2724466 | Subvenite 10 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2724466 | Subvenite 10 MG/mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2724466 | Subvenite 10 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2724466 | Subvenite 10 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 27245 | Hydroxyethylflurazepam | Designated preferred name (PT) | NO | |
| RxCUI: 27245 | Hydroxyethylflurazepam | Full form of descriptor (FN) | NO | |
| RxCUI: 27249 | Hydroxyethylthiazole kinase | Designated preferred name (PT) | NO | |
| RxCUI: 27249 | Hydroxyethylthiazole kinase | Full form of descriptor (FN) | NO | |
| RxCUI: 2725083 | ustekinumab-hmny | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2725084 | ustekinumab-hmny 90 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725087 | ustekinumab-hmny 45 MG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725087 | ustekinumab-hmny 45 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725087 | ustekinumab-hmny 45 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725088 | ustekinumab-hmny 90 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2725088 | ustekinumab-hmny 90 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725089 | Starjemza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725090 | ustekinumab-hmny 90 MG/ML [Starjemza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725091 | Starjemza Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725092 | ustekinumab Prefilled Syringe [Starjemza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725094 | STARJEMZA 45 MG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725094 | STARJEMZA 45 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725094 | STARJEMZA 45 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725095 | STARJEMZA 90 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2725095 | STARJEMZA 90 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725095 | STARJEMZA 90 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725099 | ustekinumab-hmny 90 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725099 | ustekinumab-hmny 90 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725099 | ustekinumab-hmny 90 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725100 | STARJEMZA 90 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725100 | STARJEMZA 90 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725100 | STARJEMZA 90 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725102 | ustekinumab-hmny 45 MG in 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725102 | ustekinumab-hmny 45 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725102 | ustekinumab-hmny 45 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725103 | ustekinumab-hmny 90 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2725103 | ustekinumab-hmny 90 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725104 | ustekinumab Injection [Starjemza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725106 | STARJEMZA 45 MG in 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725106 | STARJEMZA 45 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725106 | STARJEMZA 45 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725107 | STARJEMZA 90 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2725107 | STARJEMZA 90 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725107 | STARJEMZA 90 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725110 | ustekinumab-hmny 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725111 | ustekinumab-hmny 130 MG in 26 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725111 | ustekinumab-hmny 130 MG in 26 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725111 | ustekinumab-hmny 130 MG in 26 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725112 | ustekinumab-hmny 5 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2725112 | ustekinumab-hmny 5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725113 | ustekinumab-hmny 5 MG/ML [Starjemza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725114 | STARJEMZA 130 MG in 26 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725114 | STARJEMZA 130 MG in 26 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725114 | STARJEMZA 130 MG in 26 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725115 | STARJEMZA 5 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2725115 | STARJEMZA 5 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725115 | STARJEMZA 5 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725120 | roflumilast 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725121 | roflumilast 0.05 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725121 | roflumilast 0.05 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725121 | roflumilast 0.05 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725122 | roflumilast 0.5 MG/ML [Zoryve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725123 | ZORYVE 0.05 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725123 | ZORYVE 0.05 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725123 | ZORYVE 0.05 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725131 | Tyzavan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725132 | vancomycin 5 MG/ML [Tyzavan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725133 | Tyzavan Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725134 | vancomycin Injection [Tyzavan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725135 | Tyzavan 1 GM in 200 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725135 | Tyzavan 1 GM in 200 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725135 | Tyzavan 1 GM in 200 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725135 | Tyzavan 1 GM in 200 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725136 | vancomycin 5 MG/ML Injection [Tyzavan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725136 | vancomycin 5 MG/ML Injection [Tyzavan] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725157 | escitalopram 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725158 | escitalopram Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2725159 | escitalopram 15 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725159 | escitalopram 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725159 | escitalopram 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725163 | clotrimazole Otic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2725164 | clotrimazole Otic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2725165 | clotrimazole 1 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725165 | clotrimazole 1 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725165 | clotrimazole 1 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725166 | bimatoprost 0.0001 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725167 | bimatoprost Ophthalmic Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2725168 | bimatoprost 0.01 % Ophthalmic Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725168 | bimatoprost 0.01 % Ophthalmic Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725168 | bimatoprost 0.01 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725169 | natalizumab-sztn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2725170 | natalizumab-sztn 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725173 | natalizumab-sztn 300 MG in 15 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725173 | natalizumab-sztn 300 MG in 15 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725173 | natalizumab-sztn 300 MG in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725174 | natalizumab-sztn 20 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2725174 | natalizumab-sztn 20 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725175 | Tyruko | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725176 | natalizumab-sztn 20 MG/ML [Tyruko] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725177 | Tyruko Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725178 | natalizumab Injection [Tyruko] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725180 | Tyruko 300 MG in 15 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725180 | Tyruko 300 MG in 15 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725180 | Tyruko 300 MG in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725181 | Tyruko 20 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725181 | Tyruko 20 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2725181 | Tyruko 20 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725182 | Evexithroid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725183 | thyroid (USP) 15 MG [Evexithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725184 | Evexithroid Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725185 | Evexithroid Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725186 | thyroid (USP) Oral Tablet [Evexithroid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725187 | Evexithroid 15 MG (1/4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725187 | Evexithroid 15 MG (1/4 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725187 | Evexithroid 15 MG (1/4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725187 | Evexithroid 15 MG (1/4 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725188 | thyroid (USP) 30 MG [Evexithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725189 | Evexithroid 30 MG (1/2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725189 | Evexithroid 30 MG (1/2 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725189 | Evexithroid 30 MG (1/2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725189 | Evexithroid 30 MG (1/2 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725190 | thyroid (USP) 60 MG [Evexithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725191 | Evexithroid 60 MG (1 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725191 | Evexithroid 60 MG (1 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725191 | Evexithroid 60 MG (1 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725191 | Evexithroid 60 MG (1 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725192 | thyroid (USP) 120 MG [Evexithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725193 | Evexithroid 120 MG (2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725193 | Evexithroid 120 MG (2 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725193 | Evexithroid 120 MG (2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725193 | Evexithroid 120 MG (2 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725194 | thyroid (USP) 180 MG [Evexithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725195 | Evexithroid 180 MG (3 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725195 | Evexithroid 180 MG (3 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725195 | Evexithroid 180 MG (3 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725195 | Evexithroid 180 MG (3 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725196 | thyroid (USP) 45 MG [Evexithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725197 | Evexithroid 45 MG (3/4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725197 | Evexithroid 45 MG (3/4 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725197 | Evexithroid 45 MG (3/4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725197 | Evexithroid 45 MG (3/4 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725198 | thyroid (USP) 75 MG [Evexithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725199 | Evexithroid 75 MG (1 1/4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725199 | Evexithroid 75 MG (1 1/4 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725199 | Evexithroid 75 MG (1 1/4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725199 | Evexithroid 75 MG (1 1/4 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725200 | thyroid (USP) 90 MG [Evexithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725201 | Evexithroid 90 MG (1 1/2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725201 | Evexithroid 90 MG (1 1/2 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725201 | Evexithroid 90 MG (1 1/2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725201 | Evexithroid 90 MG (1 1/2 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725486 | Kymbee | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725487 | deflazacort 6 MG [Kymbee] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725488 | Kymbee Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725489 | Kymbee Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725490 | deflazacort Oral Tablet [Kymbee] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725491 | KYMBEE 6 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725491 | KYMBEE 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725491 | KYMBEE 6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725492 | deflazacort 18 MG [Kymbee] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725493 | KYMBEE 18 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725493 | KYMBEE 18 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725493 | KYMBEE 18 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725494 | deflazacort 30 MG [Kymbee] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725495 | KYMBEE 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725495 | KYMBEE 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725495 | KYMBEE 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725496 | deflazacort 36 MG [Kymbee] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725497 | KYMBEE 36 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725497 | KYMBEE 36 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725497 | KYMBEE 36 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725498 | denosumab-dssb | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2725499 | denosumab-dssb 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725502 | denosumab-dssb 60 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725502 | denosumab-dssb 60 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725502 | denosumab-dssb 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725503 | denosumab-dssb 60 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725504 | Ospomyv | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725505 | denosumab-dssb 60 MG/ML [Ospomyv] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725506 | Ospomyv Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725507 | denosumab Prefilled Syringe [Ospomyv] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725509 | OSPOMYV 60 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725509 | OSPOMYV 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725509 | OSPOMYV 60 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725509 | OSPOMYV 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725510 | denosumab-dssb 60 MG/ML Prefilled Syringe [Ospomyv] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725510 | denosumab-dssb 60 MG/ML Prefilled Syringe [Ospomyv] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725511 | elinzanetant | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2725512 | elinzanetant 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725513 | elinzanetant Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2725514 | elinzanetant Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2725515 | elinzanetant Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2725516 | elinzanetant 60 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725516 | elinzanetant 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725517 | Lynkuet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725518 | elinzanetant 60 MG [Lynkuet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725519 | Lynkuet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725520 | Lynkuet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725521 | elinzanetant Oral Capsule [Lynkuet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725522 | Lynkuet 60 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725522 | Lynkuet 60 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725522 | Lynkuet 60 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725523 | nerandomilast | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2725524 | nerandomilast 9 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725525 | nerandomilast Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2725526 | nerandomilast Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2725527 | nerandomilast Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2725528 | nerandomilast 9 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725528 | nerandomilast 9 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725529 | Jascayd | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725530 | nerandomilast 9 MG [Jascayd] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725531 | Jascayd Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725532 | Jascayd Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725533 | nerandomilast Oral Tablet [Jascayd] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725534 | JASCAYD 9 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725534 | JASCAYD 9 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725534 | JASCAYD 9 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725536 | nerandomilast 18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725537 | nerandomilast 18 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725537 | nerandomilast 18 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725538 | nerandomilast 18 MG [Jascayd] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725539 | JASCAYD 18 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725539 | JASCAYD 18 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725539 | JASCAYD 18 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725541 | furosemide 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725542 | furosemide 80 MG in 2.67 ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725542 | furosemide 80 MG in 2.67 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725542 | furosemide 80 MG in 2.67 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725543 | furosemide 30 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725544 | furosemide 30 MG/ML [Lasix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725545 | furosemide Cartridge [Lasix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725546 | Lasix ONYU 80 MG in 2.67 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725546 | Lasix ONYU 80 MG in 2.67 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725546 | Lasix ONYU 80 MG in 2.67 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725546 | Lasix ONYU 80 MG in 2.67 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725547 | furosemide 30 MG/ML Cartridge [Lasix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725547 | furosemide 30 MG/ML Cartridge [Lasix] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725548 | calcium gluconate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725549 | calcium gluconate 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725549 | calcium gluconate 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725551 | clonidine hydrochloride 0.02 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725551 | clonidine hydrochloride 0.02 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2725552 | clonidine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2725552 | clonidine Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2725553 | clonidine hydrochloride Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2725554 | cloNIDine hydrochloride 0.02 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725554 | cloNIDine hydrochloride 0.02 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725554 | cloNIDine hydrochloride 0.02 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2725555 | Javadin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725556 | clonidine hydrochloride 0.02 MG/ML [Javadin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725556 | clonidine hydrochloride 0.02 MG/ML [Javadin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2725557 | Javadin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725558 | Javadin Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725559 | clonidine Oral Solution [Javadin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725559 | clonidine Oral Solution [Javadin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2725560 | clonidine hydrochloride Oral Solution [Javadin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2725561 | Javadin 0.02 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725561 | Javadin 0.02 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2725561 | Javadin 0.02 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725561 | Javadin 0.02 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725562 | denosumab-qbde | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2725563 | denosumab-qbde 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725566 | denosumab-qbde 60 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725566 | denosumab-qbde 60 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725566 | denosumab-qbde 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725567 | denosumab-qbde 60 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725568 | Enoby | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725569 | denosumab-qbde 60 MG/ML [Enoby] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725570 | Enoby Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725571 | denosumab Prefilled Syringe [Enoby] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725573 | Enoby 60 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725573 | Enoby 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725573 | Enoby 60 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725573 | Enoby 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725574 | denosumab-qbde 60 MG/ML Prefilled Syringe [Enoby] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725574 | denosumab-qbde 60 MG/ML Prefilled Syringe [Enoby] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725575 | fosfomycin 6000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725576 | fosfomycin Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2725577 | fosfomycin 6 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725577 | fosfomycin 6 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725577 | fosfomycin 6 GM Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725578 | Contepo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725579 | fosfomycin 6000 MG [Contepo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725580 | Contepo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725581 | fosfomycin Injection [Contepo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725582 | Contepo 6 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725582 | Contepo 6 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725582 | Contepo 6 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725582 | Contepo 6 GM Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725584 | belantamab mafodotin-blmf 70 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725585 | belantamab mafodotin-blmf 70 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725585 | belantamab mafodotin-blmf 70 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725586 | belantamab mafodotin-blmf 70 MG [Blenrep] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725587 | BLENREP 70 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725587 | BLENREP 70 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725587 | BLENREP 70 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725588 | denosumab-qbde 70 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725590 | denosumab-qbde 120 MG in 1.7 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725590 | denosumab-qbde 120 MG in 1.7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725590 | denosumab-qbde 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725591 | denosumab-qbde 70 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725592 | Xtrenbo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725593 | denosumab-qbde 70 MG/ML [Xtrenbo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725594 | Xtrenbo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725595 | denosumab Injection [Xtrenbo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725597 | Xtrenbo 120 MG in 1.7 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725597 | Xtrenbo 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725597 | Xtrenbo 120 MG in 1.7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725597 | Xtrenbo 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725598 | denosumab-qbde 70 MG/ML Injection [Xtrenbo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725598 | denosumab-qbde 70 MG/ML Injection [Xtrenbo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725599 | elamipretide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2725600 | elamipretide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2725601 | elamipretide 80 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725602 | elamipretide Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2725603 | elamipretide Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2725604 | elamipretide 280 MG in 3.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725604 | elamipretide 280 MG in 3.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725604 | elamipretide 280 MG in 3.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725605 | elamipretide 80 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725606 | Forzinity | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725607 | elamipretide 80 MG/ML [Forzinity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725608 | Forzinity Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725609 | elamipretide Injection [Forzinity] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725610 | FORZINITY 280 MG in 3.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725610 | FORZINITY 280 MG in 3.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725610 | FORZINITY 280 MG in 3.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725610 | FORZINITY 280 MG in 3.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725611 | elamipretide 80 MG/ML Injection [Forzinity] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725611 | elamipretide 80 MG/ML Injection [Forzinity] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725612 | inositol 650 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725612 | inositol 650 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725613 | norepinephrine 0.128 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725614 | norepinephrine bitartrate 32 MG in 250 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725614 | norepinephrine bitartrate 32 MG in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725614 | norepinephrine bitartrate 32 MG in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725615 | norepinephrine 0.128 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725616 | Zolymbus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725617 | bimatoprost 0.0001 MG/MG [Zolymbus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725618 | Zolymbus Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725619 | bimatoprost Ophthalmic Gel [Zolymbus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725620 | ZOLYMBUS 0.01 % Ophthalmic Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725620 | ZOLYMBUS 0.01 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725620 | ZOLYMBUS 0.01 % Ophthalmic Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725620 | ZOLYMBUS 0.01 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725622 | Clotic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725623 | clotrimazole 10 MG/ML [Clotic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725624 | Clotic Otic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725625 | clotrimazole Otic Solution [Clotic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725626 | Clotic 1 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725626 | Clotic 1 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725626 | Clotic 1 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725626 | Clotic 1 % Otic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725627 | betaine hydrochloride 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725631 | betaine hydrochloride 300 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725631 | betaine hydrochloride 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725632 | glucosamine hydrochloride 500 MG / methylsulfonylmethane 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725632 | glucosamine hydrochloride 500 MG / methylsulfonylmethane 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725632 | glucosamine hydrochloride 500 MG / methylsulfonylmethane 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725633 | diclofenac sodium 1 % / lidocaine hydrochloride 5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725633 | diclofenac sodium 1 % / lidocaine hydrochloride 5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725633 | diclofenac sodium 1 % / lidocaine hydrochloride 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725885 | aflibercept-boav | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2725886 | aflibercept-boav 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725889 | aflibercept-boav 2 MG in 0.05 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725889 | aflibercept-boav 2 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725889 | aflibercept-boav 2 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725890 | aflibercept-boav 40 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725891 | Eydenzelt | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725892 | aflibercept-boav 40 MG/ML [Eydenzelt] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725893 | Eydenzelt Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725894 | aflibercept Prefilled Syringe [Eydenzelt] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725896 | Eydenzelt 2 MG in 0.05 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725896 | Eydenzelt 2 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725896 | Eydenzelt 2 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725896 | Eydenzelt 2 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725897 | aflibercept-boav 40 MG/ML Prefilled Syringe [Eydenzelt] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725897 | aflibercept-boav 40 MG/ML Prefilled Syringe [Eydenzelt] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725899 | aflibercept-boav 2 MG in 0.05 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725899 | aflibercept-boav 2 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725899 | aflibercept-boav 2 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 27259 | Hydroxylamine oxidase | Designated preferred name (PT) | NO | |
| RxCUI: 27259 | Hydroxylamine oxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 2725900 | aflibercept-boav 40 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725901 | aflibercept Injection [Eydenzelt] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725903 | Eydenzelt 2 MG in 0.05 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725903 | Eydenzelt 2 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725903 | Eydenzelt 2 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725903 | Eydenzelt 2 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725904 | aflibercept-boav 40 MG/ML Injection [Eydenzelt] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725904 | aflibercept-boav 40 MG/ML Injection [Eydenzelt] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725905 | denosumab-nxxp 60 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725905 | denosumab-nxxp 60 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725905 | denosumab-nxxp 60 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725906 | denosumab-nxxp 60 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725907 | denosumab Injection [Bildyos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725909 | BILDYOS 60 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725909 | BILDYOS 60 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725909 | BILDYOS 60 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725909 | BILDYOS 60 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725910 | denosumab-nxxp 60 MG/ML Injection [Bildyos] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725910 | denosumab-nxxp 60 MG/ML Injection [Bildyos] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725911 | imlunestrant tosylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2725912 | imlunestrant | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2725913 | imlunestrant 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725914 | imlunestrant Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2725915 | imlunestrant Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2725916 | imlunestrant Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2725917 | imlunestrant 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725917 | imlunestrant 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725917 | imlunestrant 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725918 | Inluriyo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725919 | imlunestrant 200 MG [Inluriyo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725920 | Inluriyo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725921 | Inluriyo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725922 | imlunestrant Oral Tablet [Inluriyo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725923 | Inluriyo 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725923 | Inluriyo 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725923 | Inluriyo 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725924 | denosumab-kyqq | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2725925 | denosumab-kyqq 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725928 | denosumab-kyqq 60 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725928 | denosumab-kyqq 60 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725928 | denosumab-kyqq 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725929 | denosumab-kyqq 60 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725930 | Bosaya | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725931 | denosumab-kyqq 60 MG/ML [Bosaya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725932 | Bosaya Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725933 | denosumab Prefilled Syringe [Bosaya] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725935 | Bosaya 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725935 | Bosaya 60 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725935 | Bosaya 60 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725935 | Bosaya 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725936 | denosumab-kyqq 60 MG/ML Prefilled Syringe [Bosaya] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725936 | denosumab-kyqq 60 MG/ML Prefilled Syringe [Bosaya] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725937 | denosumab-kyqq 70 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725939 | denosumab-kyqq 120 MG in 1.7 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725939 | denosumab-kyqq 120 MG in 1.7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725939 | denosumab-kyqq 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725940 | denosumab-kyqq 70 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2725941 | Aukelso | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725942 | denosumab-kyqq 70 MG/ML [Aukelso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725943 | Aukelso Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725944 | denosumab Injection [Aukelso] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725946 | Aukelso 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725946 | Aukelso 120 MG in 1.7 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725946 | Aukelso 120 MG in 1.7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725946 | Aukelso 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725947 | denosumab-kyqq 70 MG/ML Injection [Aukelso] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2725947 | denosumab-kyqq 70 MG/ML Injection [Aukelso] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2725985 | ziftomenib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2725986 | ziftomenib 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2725987 | ziftomenib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2725988 | ziftomenib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2725989 | ziftomenib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2725990 | ziftomenib 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725990 | ziftomenib 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2725991 | Komzifti | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2725992 | ziftomenib 200 MG [Komzifti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2725993 | Komzifti Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725994 | Komzifti Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2725995 | ziftomenib Oral Capsule [Komzifti] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2725996 | komzifti 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2725996 | komzifti 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2725996 | komzifti 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2725997 | omalizumab-igec | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2725998 | omalizumab-igec 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 27260 | Hydroxylamine reductase | Designated preferred name (PT) | NO | |
| RxCUI: 27260 | Hydroxylamine reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 2726001 | omalizumab-igec 150 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2726001 | omalizumab-igec 150 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726001 | omalizumab-igec 150 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726002 | omalizumab-igec 150 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2726003 | Omlyclo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2726004 | omalizumab-igec 150 MG/ML [Omlyclo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2726005 | Omlyclo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2726006 | omalizumab Prefilled Syringe [Omlyclo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2726008 | Omlyclo 150 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2726008 | Omlyclo 150 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726008 | Omlyclo 150 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726008 | Omlyclo 150 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726009 | omalizumab-igec 150 MG/ML Prefilled Syringe [Omlyclo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2726009 | omalizumab-igec 150 MG/ML Prefilled Syringe [Omlyclo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2726010 | omalizumab-igec 75 MG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2726010 | omalizumab-igec 75 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726010 | omalizumab-igec 75 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726011 | Omlyclo 75 MG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2726011 | Omlyclo 75 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726011 | Omlyclo 75 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726011 | Omlyclo 75 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726012 | immune globulin intravenous (human) - kthm | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2726013 | immune globulin intravenous (human) - kthm 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2726016 | immune globulin intravenous (human) - kthm 10 % in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2726016 | immune globulin intravenous (human) - kthm 10 % in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726016 | immune globulin intravenous (human) - kthm 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726017 | immune globulin intravenous (human) - kthm 100 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2726018 | Qivigy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2726019 | immune globulin intravenous (human) - kthm 100 MG/ML [Qivigy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2726020 | Qivigy Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2726021 | immunoglobulin G Injection [Qivigy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2726023 | QIVIGY 10 % in 50 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2726023 | QIVIGY 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726023 | QIVIGY 10 % in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726023 | QIVIGY 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726024 | immune globulin intravenous (human) - kthm 100 MG/ML Injection [Qivigy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2726024 | immune globulin intravenous (human) - kthm 100 MG/ML Injection [Qivigy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2726024 | immune globulin intravenous (human) - kthm 100 MG/ML Injection [Qivigy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2726025 | immune globulin intravenous (human) - kthm 10 % in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2726025 | immune globulin intravenous (human) - kthm 10 % in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726025 | immune globulin intravenous (human) - kthm 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726026 | Qivigy 10 % in 100 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2726026 | Qivigy 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726026 | Qivigy 10 % in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726026 | Qivigy 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726032 | denosumab-dssb 70 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2726034 | denosumab-dssb 120 MG in 1.7 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2726034 | denosumab-dssb 120 MG in 1.7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726034 | denosumab-dssb 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726035 | denosumab-dssb 70 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2726036 | Xbryk | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2726037 | denosumab-dssb 70 MG/ML [Xbryk] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2726038 | Xbryk Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2726039 | denosumab Injection [Xbryk] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2726041 | Xbryk 120 MG in 1.7 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2726041 | Xbryk 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726041 | Xbryk 120 MG in 1.7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726041 | Xbryk 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726042 | denosumab-dssb 70 MG/ML Injection [Xbryk] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2726042 | denosumab-dssb 70 MG/ML Injection [Xbryk] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2726043 | lisdexamfetamine dimesylate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2726044 | lisdexamfetamine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2726045 | lisdexamfetamine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2726048 | lisdexamfetamine dimesylate 10 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726048 | lisdexamfetamine dimesylate 10 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726048 | lisdexamfetamine dimesylate 10 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2726049 | Arynta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2726050 | lisdexamfetamine dimesylate 10 MG/ML [Arynta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2726051 | Arynta Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2726052 | Arynta Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2726053 | lisdexamfetamine Oral Solution [Arynta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2726055 | Arynta 10 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726055 | Arynta 10 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726055 | Arynta 10 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726055 | Arynta 10 MG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2726056 | amlodipine Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2726056 | amlodipine Oral Powder Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726057 | amlodipine Powder for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2726057 | amlodipine Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726058 | amLODIPine 2.5 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726058 | amLODIPine 2.5 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726058 | amLODIPine 2.5 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726058 | amLODIPine 2.5 MG Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2726058 | amLODIPine 2.5 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726059 | Sdamlo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2726060 | amlodipine 2.5 MG [Sdamlo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2726060 | amlodipine 2.5 MG [Sdamlo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726061 | Sdamlo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2726062 | Sdamlo Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2726063 | amlodipine Powder for Oral Solution [Sdamlo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2726063 | amlodipine Powder for Oral Solution [Sdamlo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726064 | Sdamlo 2.5 MG Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2726064 | Sdamlo 2.5 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726064 | Sdamlo 2.5 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726064 | Sdamlo 2.5 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726065 | amLODIPine 5 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726065 | amLODIPine 5 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726065 | amLODIPine 5 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726065 | amLODIPine 5 MG Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2726065 | amLODIPine 5 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726066 | amlodipine 5 MG [Sdamlo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2726066 | amlodipine 5 MG [Sdamlo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726067 | Sdamlo 5 MG Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2726067 | Sdamlo 5 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726067 | Sdamlo 5 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726067 | Sdamlo 5 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726068 | amLODIPine 10 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726068 | amLODIPine 10 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726068 | amLODIPine 10 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726068 | amLODIPine 10 MG Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2726068 | amLODIPine 10 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726069 | amlodipine 10 MG [Sdamlo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2726069 | amlodipine 10 MG [Sdamlo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726070 | Sdamlo 10 MG Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2726070 | Sdamlo 10 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2726070 | Sdamlo 10 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726070 | Sdamlo 10 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 27261 | Hydroxylamine reductase (reduced nicotinamide adenine dinucleotide) | Designated preferred name (PT) | NO | |
| RxCUI: 27261 | Hydroxylamine reductase (reduced nicotinamide adenine dinucleotide) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27261 | Hydroxylamine reductase (reduced nicotinamide adenine dinucleotide) | Full form of descriptor (FN) | NO | |
| RxCUI: 2726116 | ustekinumab-aekn 45 MG in 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2726116 | ustekinumab-aekn 45 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726116 | ustekinumab-aekn 45 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726116 | ustekinumab-aekn 45 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726117 | ustekinumab-aekn 90 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2726118 | Selarsdi 90 MG/ML in 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2726118 | Selarsdi 90 MG/ML in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726118 | Selarsdi 90 MG/ML in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2726118 | Selarsdi 90 MG/ML in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2726119 | ustekinumab-aekn 90 MG/ML Injection [Selarsdi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2726119 | ustekinumab-aekn 90 MG/ML Injection [Selarsdi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 27267 | Hydroxylysine kinase | Designated preferred name (PT) | NO | |
| RxCUI: 27267 | Hydroxylysine kinase | Full form of descriptor (FN) | NO | |
| RxCUI: 27274 | HMG-CoA reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27274 | HMG-CoA reductase | Designated preferred name (PT) | NO | |
| RxCUI: 27274 | HMG-CoA reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27274 | HMG-CoA reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27274 | HMG-CoA reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 272758 | gallium (67Ga) citrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 272758 | gallium (67Ga) citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 27278 | Hydroxymethylpyrimidine kinase | Designated preferred name (PT) | NO | |
| RxCUI: 27278 | Hydroxymethylpyrimidine kinase | Full form of descriptor (FN) | NO | |
| RxCUI: 2728 | Collodion | Designated preferred name (PT) | NO | |
| RxCUI: 2728 | Collodion | Full form of descriptor (FN) | NO | |
| RxCUI: 272811 | Progest | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 27288 | 4-hydroxyproline epimerase | Designated preferred name (PT) | NO | |
| RxCUI: 27288 | 4-hydroxyproline epimerase | Full form of descriptor (FN) | NO | |
| RxCUI: 27291 | hydroxypropyl cellulose | Designated preferred name (PT) | YES | |
| RxCUI: 27291 | hydroxypropyl cellulose | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 27291 | hydroxypropyl cellulose | Full form of descriptor (FN) | YES | |
| RxCUI: 27291 | hydroxypropyl cellulose | Designated preferred name (PT) | YES | |
| RxCUI: 27291 | hydroxypropyl cellulose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 27291 | hydroxypropyl cellulose | Full form of descriptor (FN) | YES | |
| RxCUI: 27296 | Hydroxypyruvate reductase | Designated preferred name (PT) | NO | |
| RxCUI: 27296 | Hydroxypyruvate reductase | Full form of descriptor (FN) | NO |
